Attached files

file filename
EX-32.2 - EX-32.2 - Morgan Stanley Direct Lending Fundexhibit322q32020.htm
EX-32.1 - EX-32.1 - Morgan Stanley Direct Lending Fundexhibit321q32020.htm
EX-31.2 - EX-31.2 - Morgan Stanley Direct Lending Fundexhibit312q32020.htm
EX-31.1 - EX-31.1 - Morgan Stanley Direct Lending Fundexhibit311q32020.htm

.______________________________________________________________________________________________________

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
______________________________________________________________________________________________________
FORM 10-Q


                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2020

OR

        TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission File Number 814-01332

Morgan Stanley Direct Lending Fund
(Exact name of registrant as specified in its charter)

 Delaware
 84-2009506
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
1585 Broadway10036
New York, NY(Zip Code)
(Address of principal executive offices)

1 (212) 761-4000
(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s) Name of each exchange on which registered
NoneNone None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes    No




Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 
Accelerated filer
Non-accelerated filer 
Smaller reporting company
Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No

As of November 6, 2020, the Registrant had 11,574,440 shares of common stock, $0.001 par value, outstanding.




MORGAN STANLEY DIRECT LENDING FUND
TABLE OF CONTENTS

Part I. Financial Information
Item 1.Consolidated Financial Statements (Unaudited)
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019
Consolidated Statements of Operations for the three and nine months ended September 30, 2020, and for the three months ended September 30, 2019 and from May 30, 2019 (inception) to September 30, 2019
Consolidated Statements of Changes in Net Assets for the three and nine months ended September 30, 2020, and for the three months ended September 30, 2019 and from May 30, 2019 (inception) to September 30, 2019
Consolidated Statements of Cash Flows for the nine months ended September 30, 2020 and from May 30, 2019 (inception) to September 30, 2019
Consolidated Schedule of Investments as of September 30, 2020
Notes to the Consolidated Financial Statements
Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3.Quantitative and Qualitative Disclosures about Market Risk
Item 4.Controls and Procedures
Part II. Other Information
Item 1.Legal Proceedings
Item 1A.Risk Factors
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds
Item 3.Defaults Upon Senior Securities
Item 4.Mine Safety Disclosures
Item 5.Other Information
Item 6.Exhibits
















2





REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the shareholders and the Board of Directors of Morgan Stanley Direct Lending Fund

Results of Review of Interim Financial Information

We have reviewed the accompanying consolidated balance sheet of Morgan Stanley Direct Lending Fund (the "Company") including the consolidated schedule of investments, as of September 30, 2020, and the related consolidated statements of operations and changes in net assets for the three-month and nine-month periods ended September 30, 2020, the three-month period ended September 30, 2019, and the period from May 30, 2019 (Inception) to September 30, 2019, and cash flows for the nine-month period ended September 30, 2020 and the period from May 30, 2019 (Inception) to September 30, 2019, and the related notes (collectively referred to as the "interim financial information"). Based on our reviews, we are not aware of any material modifications that should be made to the accompanying interim financial information for it to be in conformity with accounting principles generally accepted in the United States of America.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the balance sheet of the Company as of December 31, 2019, and the related statements of operations, changes in net assets, and cash flows for the year then ended (not presented herein); and in our report dated March 20, 2020, we expressed an unqualified opinion on those financial statements. In our opinion, the information set forth in the accompanying balance sheet as of December 31, 2019, is fairly stated, in all material respects, in relation to the balance sheet from which it has been derived.

Basis for Review Results

This interim financial information is the responsibility of the Company's management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our reviews in accordance with standards of the PCAOB. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.


/s/Deloitte & Touche LLP

New York, NY
November 6, 2020


3

Morgan Stanley Direct Lending Fund
Consolidated Balance Sheets
(In thousands, except share and per share data)


As of
September 30, 2020
As of
December 31, 2019
Assets(unaudited)
Non-controlled/non-affiliated investments, at fair value (amortized cost of $334,214 and $0 at September 30, 2020 and December 31, 2019, respectively)$336,347 $— 
Cash112,930 35 
Deferred financing costs2,076 958 
Deferred offering costs88 250 
Subscription receivable2,468 — 
Interest receivable from non-controlled/non-affiliated investments1,366 — 
Other assets20 221 
Total assets$455,295 $1,464 
Liabilities
Debt$181,350 $— 
Payable for investments purchased33,774 — 
Payable to affiliate (Note 3)1,385 1,399 
Financing costs payable1,634 605 
Dividend payable3,228 — 
Management fee payable159 — 
Incentive fees payable1,301 — 
Interest payable606 — 
Accrued expenses and other liabilities1,929 581 
Total liabilities$225,366 $2,585 
Commitments and Contingencies (Note 7)
Net Assets
Common stock, par value $0.001 per share (100,000,000 shares authorized and 11,574,440 and 1,750 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively)$12 $— 
Paid-in capital in excess of par value227,621 35 
Distributable earnings (accumulated losses)2,296 (1,156)
Total net assets$229,929 $(1,121)
Total liabilities and net assets$455,295 $1,464 
Net asset value per share$19.87 $(640.54)


The accompanying notes are an integral part of these consolidated financial statements


4

Morgan Stanley Direct Lending Fund
Consolidated Statements of Operations (Unaudited)
(In thousands, except share and per share data)


Three
months ended
September 30, 2020
Three
months ended
September 30, 2019
Nine
months ended
September 30, 2020
May 30, 2019 (inception) to
September 30, 2019
Investment income:
From non-controlled/non-affiliated investments:
Interest income$5,473 $— $9,332 $— 
Other income186 — 1,140 — 
Total investment income5,659 — 10,472 — 
Expenses:
Interest expense967 — 2,050 — 
Organization and offering costs206 278 541 584 
Professional fees715 — 1,339 — 
Directors' fees87 — 261 — 
Management fees637 — 1,059 — 
Income based incentive fees551 — 969 — 
Capital gain incentive fees750 — 750 — 
Administrative service fees54 — 140 — 
General and other expenses327 — 369 — 
Total expenses4,294 278 7,478 584 
Expense waiver (Note 3)(5)— (138)— 
Management fees waiver (Note 3)(478)— (794)— 
Net expenses3,811 278 6,546 584 
Net investment income (loss)1,848 (278)3,926 (584)
Realized and unrealized gains (loss):
Net realized gain (loss):
Non-controlled/non-affiliated investments789 — 2,154 — 
Net change in unrealized appreciation (depreciation):
Non-controlled/non-affiliated investments3,982 — 2,133 — 
Net realized and unrealized gains (loss)4,771 — 4,287 — 
Net increase (decrease) in net assets resulting from operations$6,619 $(278)$8,213 $(584)
5

Morgan Stanley Direct Lending Fund
Consolidated Statements of Operations (Unaudited) (Continued)
(In thousands, except share and per share data)

Three
months ended
September 30, 2020
Three
months ended
September 30, 2019
Nine
months ended
September 30, 2020
May 30, 2019 (inception) to
September 30, 2019
Per share information—basic and diluted
Net investment income (loss) per share (basic and diluted):$0.25 $— $0.71 $— 
Net earnings per share (basic and diluted):$0.91 $— $1.48 $— 
Weighted average shares outstanding (basic and diluted) (Note 9):7,290,085 — 5,559,741 — 
Dividend declared per share$0.40 $— $0.69 $— 

The accompanying notes are an integral part of these consolidated financial statements



























6

Morgan Stanley Direct Lending Fund
Consolidated Statements of Changes in Net Assets (Unaudited)
(In thousands, except share data)

Three
months ended
September 30, 2020
Three
months ended
September 30, 2019
Nine
months ended
September 30, 2020
May 30, 2019 (inception) to
September 30, 2019
Increase (decrease) in net assets resulting from operations:
Net investment income (loss)$1,848 $(278)$3,926 $(584)
Net realized gain (loss)789 — 2,154 — 
Net change in unrealized appreciation (depreciation)3,982 — 2,133 — 
Net increase (decrease) in net assets resulting from operations6,619 (278)8,213 (584)
Capital transactions:
Issuance of common stock109,969 10 227,371 10 
Reinvestment of dividends227 — 227 — 
Dividend declared(3,228)— (4,761)— 
Net increase (decrease) in net assets resulting from capital transactions106,968 10 222,837 10 
Total increase (decrease) in net assets113,587 (268)231,050 (574)
Net assets at beginning of period116,342 (306)(1,121)— 
Net assets at end of period$229,929 $(574)$229,929 $(574)








The accompanying notes are an integral part of these consolidated financial statements

7

Morgan Stanley Direct Lending Fund
Consolidated Statements of Cash Flow (Unaudited)
(In thousands, except share data)

  Nine months ended
September 30, 2020
May 30, 2019 (inception) to
September 30, 2019
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations$8,213 $(584)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net unrealized (appreciation) depreciation on investments(2,133)— 
Net realized (gain) loss on investments(2,154)— 
Net accretion of discount and amortization of premium(1,177)— 
Amortization of deferred financing cost637 — 
Amortization of offering cost187 — 
Purchases of investments and change in payable for investments purchased(344,573)— 
Proceeds from sale of investments and principal repayments and change in receivable for investments sold47,464 — 
Changes in operating assets and liabilities:
(Increase) decrease in interest receivable(1,366)— 
(Increase) decrease in other assets201 — 
(Increase) decrease in deferred offering costs— (150)
(Decrease) increase in payable to affiliate(39)734 
(Decrease) increase in management fees payable159 — 
(Decrease) increase in incentive fees payable1,301 — 
(Decrease) increase in interest payable606 — 
(Decrease) increase in accrued expenses and other liabilities1,348 — 
Net cash provided by (used in) operating activities(291,326)— 
Cash flows from financing activities:
Borrowings on credit facility391,350 — 
Repayments on credit facility(210,000)— 
Deferred financing costs paid(726)— 
Dividends paid in cash(1,306)— 
Proceeds from issuance of common shares224,903 10 
Offering costs paid— — 
Net cash provided by (used in) financing activities404,221 10 
Net increase (decrease) in cash and cash equivalents112,895 10 
Cash and cash equivalents, beginning of period35 — 
Cash and cash equivalents, end of period$112,930 $10 
Supplemental information and non-cash activities:
Interest paid during the period$460 $— 
Accrued but unpaid deferred financing costs$1,134 $— 
Accrued but unpaid deferred offering costs$25 $— 
Dividend payable$3,228 $— 
Dividend reinvestment paid during the period$227 $— 
Subscription receivable$2,468 $— 
The accompanying notes are an integral part of these consolidated financial statements

8

Morgan Stanley Direct Lending Fund
Consolidated Schedule of Investments (Unaudited)
September 30, 2020
(In thousands)


Investments-non-controlled/non-affiliated (1)
FootnotesReference Rate and Spread
Interest Rate(2)
Acquisition DateMaturity
Date
Par Amount/ Units
Cost(4)
Fair
Value
Percentage of
Net Assets
First Lien Debt
Automobiles
Turbo Buyer, Inc.(3) (5) (7)L + 5.50%6.50%08/21/202012/02/2025$$(426)$(427)(0.19)%
Commercial Services & Supplies
Capstone Logistics Acquisition, Inc.(3) (5) (6)L + 4.50%5.50%03/26/202010/07/202111,98710,521 11,740 5.11 
Divisions Holding Corporation(3) (5)L + 6.50%7.50%08/14/202008/14/202629,56528,984 28,984 12.60 
Divisions Holding Corporation(3) (5) (7)L + 6.50%7.50%08/14/202008/14/20261,7391,637 1,637 0.71 
Divisions Holding Corporation(3) (5) (7)L + 6.50%7.50%08/14/202008/14/2026(51)(51)(0.02)
US Infra Svcs Buyer LLC(3) (5)L + 6.00%7.00%04/10/202004/13/202617,20716,884 17,195 7.48 
US Infra Svcs Buyer LLC(3) (5) (7)L + 6.00%7.00%04/10/202004/13/2026300259 298 0.13 
US Infra Svcs Buyer LLC(3) (5) (7)L + 6.00%7.00%04/10/202004/13/2026990796 983 0.43 
59,030 60,786 26.44 
Diversified Consumer Services
Syndigo LLC(3) (5)L + 6.00%7.00%07/30/202010/24/202424,27323,804 23,804 10.35 
Syndigo LLC(3) (5) (7)L + 6.00%7.00%07/30/202010/24/2024— — — 
23,804 23,804 10.35 
Food Products
Nellson Nutraceutical, Inc.(3) (5) (6)L + 5.25%6.25%09/30/202012/23/202317,71617,362 17,362 7.55 
Nellson Nutraceutical, Inc.(3) (5) (6)L + 5.25%6.25%09/30/202012/23/20237,2847,138 7,138 3.11 
24,500 24,500 10.66 
Industrial Conglomerates
Aptean, Inc.(3) (5)L + 5.25%6.25%06/30/202004/23/20261,9951,966 1,995 0.87 
Electrical Source Holdings LLC(3) (5)L + 5.50%6.50%05/18/202011/25/202529,92529,643 29,925 13.01 
31,609 31,920 13.88 
Insurance
Integrity Marketing Acquisition LLC(3) (5) (7)L + 6.25%7.25%08/07/202008/27/2025(655)(655)(0.28)
Majesco(3) (5)L + 7.75%8.75%09/21/202009/21/202714,89014,444 14,444 6.28 
Majesco(3) (5) (7)L + 7.75%8.75%09/21/202009/21/2026(47)(47)(0.02)
RSC Acquisition, Inc.(3) (5)L + 5.50%6.50%09/11/202010/30/20262,2502,183 2,183 0.95 
RSC Acquisition, Inc.(3) (5) (7)L + 5.50%6.50%09/11/202010/30/2026(382)(382)(0.17)
World Insurance Associates LLC(3) (5)L + 5.75%6.75%05/22/202004/01/202610,2959,658 9,929 4.32 
World Insurance Associates LLC(3) (5) (7)L + 5.75%6.75%05/22/202004/01/20264,6794,390 4,512 1.96 
29,591 29,984 13.04 
IT Services
Ensono, LP(5)L + 5.75%5.89%06/25/202006/27/202514,96314,446 14,898 6.48 
Help/Systems Holdings, Inc.(3) (5)L + 4.75%5.75%06/16/202011/19/202619,90019,624 19,900 8.65 
Recovery Point Systems, Inc.(3) (5)L + 6.50%7.50%08/12/202008/12/202642,00041,175 41,175 17.91 
Recovery Point Systems, Inc.(3) (5) (7)L + 6.50%7.50%08/12/202008/12/2026(78)(78)(0.03)
75,167 75,895 33.01 
Professional Services
Bullhorn, Inc.(3) (5) (6)L + 5.75%6.75%09/11/202009/30/20267,4467,334 7,334 3.19 
Bullhorn, Inc.(3) (5) (6) (7)L + 5.75%6.75%09/11/202009/30/2026(8)(8)— 

9


Morgan Stanley Direct Lending Fund
Consolidated Schedule of Investments (Unaudited) (Continued)
September 30, 2020
(In thousands)
Investments-non-controlled/non-affiliated (1)
FootnotesReference Rate and Spread
Interest Rate(2)
Acquisition DateMaturity
Date
Par Amount/ Units
Cost(4)
Fair
Value
Percentage of
Net Assets
First Lien Debt (continued)
Professional Services (continued)
IQN Holding Corp., dba Beeline(3) (5)L + 5.50%6.50%02/10/202008/20/2024$38,176$38,009 $37,561 16.33 
IQN Holding Corp., dba Beeline(3) (5) (7)L + 5.50%6.50%02/10/202008/21/2023(19)(73)(0.03)
45,316 44,814 19.49 
Real Estate Management & Development
MRI Software LLC(3) (5)L + 5.50%6.50%01/31/202002/10/202631,36431,095 31,055 13.51 
MRI Software LLC(3) (5) (7)L + 5.50%6.50%01/31/202002/10/2026(20)(22)(0.01)
MRI Software LLC(3) (5) (7)L + 5.50%6.50%01/31/202002/10/2026(6)(12)(0.01)
MRI Software LLC(3) (5) (7)L + 5.50%6.50%08/28/202002/10/2026(167)(167)(0.07)
30,902 30,854 13.42 
Total First Lien Debt319,493 322,130 140.10 
Second Lien Debt
Energy Equipment & Services
QBS Parent, Inc.(5)L + 8.50%8.72%02/10/202009/21/202615,00014,721 14,217 6.18 
Total Second Lien Debt14,721 14,217 6.18 
Total Portfolio Investments$334,214 $336,347 146.28 %

(1)Unless otherwise indicated, issuers of debt and equity investments held by Morgan Stanley Direct Lending Fund (the "Company") are denominated in dollars. For the purpose of this Consolidated Schedule of Investments, the term “Company” shall include the Company’s consolidated subsidiaries. Under the Investment Company Act of 1940, as amended (together with the rules and regulations promulgated thereunder, the “1940 Act”), the Company would be deemed to “control” a portfolio company if the Company owned more than 25% of such portfolio company's outstanding voting securities and/or held the power to exercise control over the management or policies of such portfolio company. As of September 30, 2020, the Company does not “control” any of its portfolio companies. Under the 1940 Act, the Company would be deemed an “affiliated person” of a portfolio company if the Company owns 5% or more of the portfolio company’s outstanding voting securities. As of September 30, 2020, the Company is not an “affiliated person” of any of its portfolio companies.
(2)Variable rate loans to the portfolio companies bear interest at a rate that is determined by reference to either the London Interbank Offered Rate ("LIBOR" or "L") or an alternate base rate (commonly based on the Federal Funds Rate (“F”) or the U.S. Prime Rate (“P”)), which generally resets periodically. For each loan, the Company has indicated the reference rate used and provided the spread and the interest rate in effect as of September 30, 2020. As of September 30, 2020, the reference rates for our variable rate loans were the 1 Month L at 0.14% and 3 Month L at 0.22%.
(3)Loan includes interest rate floor feature, which is generally 1%.
(4)The cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method.
(5)These investments were valued using unobservable inputs and are considered Level 3 investments. Fair value was determined in good faith by or under the direction of the board of directors of the Company (the "Board") (see Note 2 and Note 5), pursuant to the Company’s valuation policy.
(6)Position or portion thereof unsettled as of September 30, 2020.
(7)Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion, although the investment may earn unused commitment fees. Negative cost and fair value, if any, results from unamortized fees, which are capitalized to the cost of the investment. The unfunded loan commitment may be subject to a commitment termination date that may expire prior to the maturity date stated. See below for more information on the Company’s unfunded commitments as of September 30, 2020:


10

Morgan Stanley Direct Lending Fund
Consolidated Schedule of Investments (Unaudited) (Continued)
September 30, 2020
(In thousands)

Investments-non-controlled/ non-affiliatedUnused Fee RateCommitment TypeCommitment
Expiration Date
Unfunded
Commitment
Fair Value
Bullhorn, Inc.0.50%Revolver09/30/2026$554$(8)
Divisions Holding Corporation0.50%Revolver08/14/20263,478(68)
Divisions Holding Corporation1.00%Delayed Draw Term Loan08/14/20225,217(51)
Integrity Marketing Acquisition LLC1.00%Delayed Draw Term Loan02/07/202245,000(655)
IQN Holding Corp., dba Beeline0.50%Revolver08/21/20234,545(73)
Majesco0.50%Revolver09/21/20261,575(47)
MRI Software LLC0.50%Revolver02/10/20262,215(22)
MRI Software LLC0.50%Delayed Draw Term Loan02/10/20221,263(12)
MRI Software LLC1.00%Incremental Delayed Draw Term Loan08/28/202217,000(167)
Recovery Point Systems, Inc.0.50%Revolver08/12/20264,000(78)
RSC Acquisition, Inc.1.00%Delayed Draw Term Loan03/31/202212,750(383)
Syndigo LLC0.00%Delayed Draw Term Loan07/30/202112,167
Turbo Buyer, Inc.1.00%Incremental Delayed Draw Term Loan02/21/202235,000(427)
US Infra Svcs Buyer LLC0.50%Revolver04/13/20261,950(1)
US Infra Svcs Buyer LLC1.00%Delayed Draw Term Loan04/13/20229,510(7)
Total First Lien Debt Unfunded Commitments156,224(1,999)
Total Unfunded Commitments
$156,224$(1,999)



The accompanying notes are an integral part of these consolidated financial statements

11

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)



(1)Organization

Morgan Stanley Direct Lending Fund (collectively with its subsidiaries, the “Company”) is an externally managed specialty finance company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940 Act, as amended (the “1940 Act”). In addition, for U.S. federal income tax purposes, the Company intends to elect to be treated, and to comply with the requirements to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

The Company was formed as a Delaware limited liability company on May 30, 2019 and converted into a corporation and succeeded to the business of Morgan Stanley Direct Lending Fund LLC on November 25, 2019 (the “BDC Conversion”). The Company commenced investing operations on January 31, 2020. On November 25, 2019, the Company entered into an investment advisory agreement, (the "Investment Advisory Agreement") with MS Capital Partners Adviser Inc., the investment adviser to the Company (the “Investment Adviser”). The Investment Adviser is an indirect wholly owned subsidiary of Morgan Stanley.

The Company’s investment objective is to achieve attractive risk-adjusted returns via current income and, to a lesser extent, capital appreciation by investing primarily in directly originated senior secured term loans issued by U.S. middle market companies backed by financial sponsors.

The Company is conducting private offerings (the "Private Offerings") of shares of its common stock, par value $0.001 per share (the “Common Stock”), to investors in reliance on exemptions from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). At the closing of any Private Offering, each investor makes a capital commitment (a “Capital Commitment”) to purchase shares of Common Stock pursuant to a subscription agreement entered into with the Company (each, a "Subscription Agreement"). Investors are required to fund drawdowns to purchase shares of Common Stock up to the amount of their respective Capital Commitments each time the Company delivers a notice to the investors.

DLF CA SPV LLC (“CA SPV”) is a Delaware limited liability company that was formed on February 26, 2020. CA SPV expects to hold investments in first and second lien senior secured loans. CA SPV is a wholly owned subsidiary of the Company and is consolidated in these consolidated financial statements commencing from the date of its formation.

DLF SPV LLC (“DLF SPV”) is a Delaware limited liability company that was formed on August 7, 2020. DLF SPV expects to hold investments in first and second lien senior secured loans. DLF SPV is a wholly owned subsidiary of the Company and is consolidated in these consolidated financial statements commencing from the date of its formation.

DLF Financing SPV LLC (“DLF LLC”) is a Delaware limited liability company that was formed on September 17, 2020. DLF LLC expects to hold investments in first and second lien senior secured loans. DLF LLC is a wholly owned subsidiary of the Company and is consolidated in these consolidated financial statements commencing from the date of its formation.
(2)Summary of Significant Accounting Policies
Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). As an investment company, the Company applies the accounting and reporting guidance in Accounting Standards Codification (“ASC”) Topic 946, Financial Services – Investment Companies issued by the Financial Accounting Standards Board (“FASB”). The carrying value for all assets and liabilities approximates their fair value.

The interim consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Articles 6 and 10 of Regulation S-X. Accordingly, certain disclosures accompanying the annual consolidated financial statements prepared in accordance with U.S. GAAP are

12

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
omitted.  In the opinion of management, all adjustments, consisting solely of normal recurring accruals considered necessary for the fair presentation of financial statements for the interim period presented, have been included. The current period’s results of operations will not necessarily be indicative of results that the Company may ultimately achieve for the year ending December 31, 2020. All intercompany balances and transactions have been eliminated. Certain prior period information have been reclassified to conform to the current period presentation.
Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Such amounts could differ from those estimates and such differences could be material. Management’s estimates are based on historical experiences and other factors, including expectations of future events that management believes to be reasonable under the circumstances. Assumptions and estimates regarding the valuation of investments involve a higher degree of judgment and complexity and these assumptions and estimates may be significant to the consolidated financial statements.

Cash

Cash is carried at cost, which approximates fair value. The Company deposits its cash with multiple financial institutions and, at times, may exceed the Federal Deposit Insurance Corporation insured limit.
Investments

Investment transactions are recorded on the trade date. Realized gains or losses are measured by the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include investments charged off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment values, including the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period. See Note 5 for further information about fair value measurements.
Revenue Recognition

Interest Income

Interest income is recorded on an accrual basis and includes the accretion of discounts and amortizations of premiums.  Discounts from and premiums to par value on debt investments purchased are accreted/amortized into interest income over the life of the respective security using the effective interest method.  The amortized cost of debt investments represents the original cost, including loan origination fees and upfront fees received that are deemed to be an adjustment to yield, adjusted for the accretion of discounts and amortization of premiums, if any.  Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income in the current period.

Other Income

    The Company may receive various fees in the ordinary course of business such as structuring, consent, waiver, amendment and syndication fees as well as fees for managerial assistance rendered by the Company to the portfolio companies.  Such fees are recognized in income when earned or when the services are rendered and there is no uncertainty or contingency related to the amount to be received.  


13

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
Non-Accrual Income

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected in full.  Accrued interest is generally reversed when a loan is placed on non-accrual status. Additionally, any original issue discount and market discount are no longer accreted to interest income as of the date the loan is placed on non-accrual status.  Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest are paid current and, in management’s judgment, are likely to remain current. Management may determine to not place a loan on non-accrual status if the loan has sufficient collateral value and is in the process of collection.

Realized Gains/Losses

Realized gains or losses on investments are measured by the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment using the specific identification method.

Organization and Offering Costs

Costs associated with the organization of the Company are expensed as incurred, subject to the limitations discussed below. These costs consist primarily of legal fees and other costs of organizing the Company. Costs associated with the offering of Common Stock are capitalized as “deferred offering costs” on the Consolidated Balance Sheets and amortized over a twelve-month period from the initial capital call, subject to the limitation described in Note 3 below. These costs consist primarily of legal fees and other costs incurred in connection with the Company’s continuous Private Offerings of its Common Stock.
Expenses

The Company is responsible for investment expenses, legal expenses, auditing fees and other expenses related to the Company’s operations. Such fees and expenses, including expenses incurred by the Investment Adviser on behalf of the Company, will be reimbursed by the Company, subject to contractual thresholds.

The Company pays the Investment Adviser a base management fee and an incentive fee under the Investment Advisory Agreement as described in Note 3 below. The fees are recorded in the Consolidated Statements of Operations.
Deferred Financing Costs

Deferred financing costs represent upfront fees, legal and other direct incremental costs incurred in connection with the Company’s borrowings. These costs are deferred and will be amortized over the life of the related borrowings using the straight-line method. Deferred financing costs related to revolving credit facilities are presented separately as an asset on the Company’s Consolidated Balance Sheets.
Income Taxes

The Company intends to elect to be treated as a RIC under Subchapter M of the Code. So long as the Company maintains its status as a RIC, it generally will not pay corporate U.S. federal income taxes on any ordinary income or capital gains that it distributes at least annually to its stockholders as dividends.

In order to qualify as a RIC, the Company must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Company is generally required to pay income taxes only on the portion of its taxable income and gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Company to distribute to its stockholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax

14

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
year, the Company may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

In addition, based on the excise distribution requirements, the Company is subject to a 4% nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to corporate income tax is considered to have been distributed. The Company intends to make sufficient distributions each taxable year to satisfy the excise distribution requirements.

The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more likely than not” to be sustained by the applicable tax authority. All penalties and interest associated with income taxes, if any, are included in income tax expense. Each of CA SPV, DLF SPV and DLF LLC is a disregarded entity for tax purposes and will be consolidated with the tax return of the Company.
New Accounting Standards

In March 2020, the Financial Accounting Standards Board issued Accounting Standards Update 2020-04 (“ASU 2020-04”) “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” This accounting update provides optional accounting relief to entities with contracts, hedge accounting relationships or other transactions that reference LIBOR or other interest rate benchmarks for which the referenced rate is expected to be discontinued or replaced. This optional relief generally allows for contract modifications solely related to the replacement of the reference rate to be accounted for as a continuation of the existing contract instead of as an extinguishment of the contract, and would therefore not trigger certain accounting impacts that would otherwise be required. The optional relief can be applied beginning January 1, 2020 and ending December 31, 2022. We plan to apply the accounting relief as relevant contract relationship modifications are made during the course of the reference rate reform transition period.

Other than the accounting guidance described above, management does not believe any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company's consolidated financial statements.

(3)Related Party Transactions

Placement Agent Agreement

On August 30, 2019, the Company entered into a placement agent agreement (the “Placement Agent Agreement”) with Morgan Stanley Distribution Inc. (the “Paying Agent”), Morgan Stanley Smith Barney LLC (the “Placement Agent”) and the Investment Adviser. Under the terms of the Placement Agent Agreement, the Placement Agent and certain of its affiliates will assist in the placement of Common Stock in the Company’s Private Offerings. The Company is not liable for any payments to the Placement Agent pursuant to the Placement Agent Agreement. Payments will be made by the Investment Adviser to the Placement Agent. To the extent the Paying Agent receives any payments, it will remit such payments to the Placement Agent.

Investment Advisory Agreement

In October 2019, the board of directors of the Company (the "Board"), including a majority of the directors who are not “interested persons” as defined in Section 2(a)(19) of the 1940 Act (the “Independent Directors”), approved the Investment Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such directors as required by, Section 15(c) of the 1940 Act for a two-year term commencing on November 25, 2019.


15

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
The Company pays the Investment Adviser a fee for its services under the Investment Advisory Agreement consisting of two components: a base management fee ("Base Management Fee") and an incentive fee. The costs of both the Base Management Fee and the incentive fee will ultimately be borne by the stockholders.

Base Management Fee

The Base Management Fee is calculated at an annual rate of 1.0% of the Company’s average gross assets at the end of the two most recently completed calendar quarters, including assets purchased with borrowed funds or other forms of leverage but excluding cash and cash equivalents. Prior to a listing of the Company's Common Stock on a national securities exchange, the Investment Adviser has agreed to irrevocably waive the portion of the Base Management Fee in excess of 0.25% of the Company’s average gross assets calculated in accordance with the Investment Advisory Agreement. Any waived Base Management Fees are not subject to recoupment by the Investment Adviser. The Base Management Fee is payable quarterly in arrears and no management fee is charged on committed but undrawn Capital Commitments.

For the three months ended September 30, 2020, base management fees were $637 and $159 net of waiver and for the nine months ended September 30, 2020, base management fees were $1,059 and $265 net of waiver.

As of September 30, 2020, $159 was payable to the Investment Adviser relating to base management fees. As of December 31, 2019, no base management fee was payable to the Investment Adviser.

Incentive Fee

The incentive fee consists of two components that are determined independently of each other, with the result that one component may be payable even if the other is not. One component is based on income and the other component is based on capital gains.
The Company pays the Investment Adviser an income based incentive fee with respect to the Company’s pre-incentive fee net investment income in each calendar quarter as follows:

• No income based incentive fee if the Company’s pre-incentive fee net investment income, expressed as a return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, does not exceed the hurdle rate of 1.5% (6.0% annualized);

• 100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 1.8182% (7.2728% annualized). This portion of the pre-incentive fee net investment income (which exceeds the hurdle rate but is less than 1.8182%) is referred to as the “catch-up”. This “catch-up” portion is meant to provide the Investment Adviser with approximately 17.5% of the Company’s pre-incentive fee net investment income as if a hurdle rate did not apply if the “catch up” is achieved; and

• 17.5% of the Company’s pre-incentive fee net investment income, if any, that exceeds the rate of return of 1.8182% (7.2728% annualized).

The second part of the incentive fee is determined on realized capital gains calculated and payable in arrears in cash as of the end of each calendar year or upon the termination of the Investment Advisory Agreement in an amount equal to 17.5% of the realized capital gains, if any, on a cumulative basis from November 25, 2019, the date of our election to be regulated as a BDC, through the end of a given calendar year or upon the termination of the Investment Advisory Agreement, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees (the "Cumulative Capital Gains").

Under U.S. GAAP, the Company is required to accrue an incentive fee on capital gains, including unrealized capital appreciation even though such unrealized capital appreciation is not included in calculating the incentive fee payable under the

16

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
Investment Advisory Agreement. If such amount is positive at the end of a period, then the Company will record an incentive fee on capital gain incentive fee equal to 17.5% of such amount, less the aggregate amount of any previously paid capital gain incentive fees. If such amount is negative, no accrual will be recorded for such period.

For the three and nine months ended September 30, 2020, $551 and $969, respectively, of income based incentive fees accrued to the Investment Adviser. For the three and nine months ended September 30, 2020, $750 and $750, respectively, of capital gain incentive fees accrued to the Investment Adviser. The Investment Advisory Agreement does not permit unrealized capital appreciation for purposes of calculating the amount payable to the Investment Adviser. Amounts due related to unrealized capital appreciation, if any, will not be paid to the Investment Adviser until realized under the terms of the Investment Advisory Agreement and determined based on the calculation. Incentive fees on Cumulative Capital Gains crystallize at calendar year-end.

As of September 30, 2020, $551 and $750 were payable to the Investment Adviser relating to income based incentive fees and capital gain incentive fees, respectively. As of December 31, 2019, no incentive fee was payable to the Investment Adviser.

Administration Agreement

MS BDC Administrative Services LLC, an affiliate of the Investment Adviser (the “Administrator”), is the administrator of the Company pursuant to an administration agreement (the “Administration Agreement”).

Pursuant to the Administration Agreement, the Administrator provides services and receives reimbursements from the Company equal to an amount that reimburses the Administrator for its costs and expenses and the Company’s allocable portion of overhead incurred by the Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the compensation paid to the Company’s Chief Compliance Officer and Chief Financial Officer. Reimbursement under the Administration Agreement occurs quarterly in arrears.

For the three and nine months ended September 30, 2020, the Company incurred $54 and $140, respectively, in expenses under the Administration Agreement, which were recorded in administrative service expenses in the Company’s Consolidated Statements of Operations. As of September 30, 2020, $140 was unpaid and included in payable to affiliate in the Consolidated Balance Sheets. As of December 31, 2019, no administrative service amount was payable to the Administrator.

Expense Support and Waiver Agreement

On December 31, 2019, the Company entered into an expense support and waiver agreement (the “Expense Support and Waiver Agreement”) with the Investment Adviser. Under the terms of the Expense Support and Waiver Agreement, the Investment Adviser agreed to waive any reimbursement by the Company of offering and organizational expenses to be incurred by the Investment Adviser on behalf of the Company in excess of $1,000 or 0.10% of the aggregate Capital Commitments of the Company, whichever is greater. If actual organization and offering costs incurred exceed the greater of $1,000 or 0.10% of the Company’s total Capital Commitments, the Investment Adviser or its affiliate will bear the excess costs. The Company shall reimburse the Investment Adviser for payments of any excess costs borne by the Investment Adviser on the Company's behalf within three years of December 23, 2019 (the "Initial Closing Date"). As of September 30, 2020 and December 31, 2019, the Investment Adviser has not recaptured any previously waived amounts from the Company since actual offering and organizational expenses incurred from May 30, 2019 (inception) to September 30, 2020 exceeded the greater of $1,000 or 0.10% of the Company's total Capital Commitments.

For the three months ended September 30, 2020, the Company incurred $206 towards organization cost and amortization of offering cost. These costs exceeded the Investment Adviser reimbursement threshold, and as a result, the excess organization cost of $5 was waived.

For the nine months ended September 30, 2020, the Company incurred $541 towards organization cost and amortization of offering cost. These costs exceeded the Investment Adviser reimbursement threshold, and as a result, the excess organization cost of $138 was waived.

For the three months ended September 30, 2019 and from May 30, 2019 (inception) to September 30, 2019, the Company incurred $278 and $584 towards organization cost.

17

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
As of September 30, 2020 and December 31, 2019, organization cost and offering cost are included in payable to affiliate and accrued expenses and other liabilities in the Consolidated Balance Sheets.

(4)Investments

The composition of the Company’s investment portfolio as of September 30, 2020 at cost and fair value was as follows:
September 30, 2020
CostFair Value% of Total Investments at Fair Value
First Lien Debt319,493 322,130 95.77 %
Second Lien Debt14,721 14,217 4.23 
Total$334,214 $336,347 100.00 %

The industry composition of investments as of September 30, 2020 at fair value was as follows:
September 30, 2020 (1)
Automobiles(0.13)%
Commercial Services & Supplies18.07 
Diversified Consumer Services7.08 
Food Products7.28 
Energy Equipment & Services4.23 
Industrial Conglomerates9.49 
Insurance8.91 
IT Services22.56 
Professional Services13.32 
Real Estate Management & Development9.17 
Total100.00 %
(1) Negative percentage is resulted from negative fair value of an unfunded loan commitment.

The geographic composition of investments as of September 30, 2020 at cost and fair value was as follows:
September 30, 2020
CostFair Value% of Total
Investments at
Fair Value
United States$334,214 $336,347 100.00 %
Total$334,214 $336,347 100.00 %

(5)Fair Value Measurements

The Company conducts the valuation of assets at all times consistent with U.S. GAAP and the 1940 Act. The Board, with the assistance of the Company's Audit Committee (the "Audit Committee"), determines the fair value of the assets, for assets with a daily public market, and for assets with no readily available public market, on at least a quarterly basis, in accordance with FASB ASC 820, Fair Value Measurements ("ASC 820"). Valuation procedures are set forth in more detail below.

ASC 820 defines fair value as "the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date." Fair value is a market-based measurement, not an entity-specific

18

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
measurement. For some assets and liabilities, observable market transactions or market information might be available. For other assets and liabilities, observable market transactions and market information might not be available. However, the objective of a fair value measurement in both cases is the same—to estimate the price when an orderly transaction to sell the asset or transfer the liability would take place between market participants at the measurement date under current market conditions (that is, an exit price at the measurement date from the perspective of a market participant that holds the asset or owes the liability).

ASC 820 establishes a hierarchical disclosure framework which ranks the observability of inputs used in measuring financial instruments at fair value. The observability of inputs is impacted by a number of factors, including the type of financial instruments and their specific characteristics. Financial instruments with readily available quoted prices, or for which fair value can be measured from quoted prices in active markets, generally will have a higher degree of market price observability and a lesser degree of judgment applied in determining fair value.

The three-level hierarchy for fair value measurements is defined as follows:

Level 1—inputs to the valuation methodology are quoted prices available in active markets for identical financial instruments as of the measurement date. The types of financial instruments in this category include unrestricted securities, including equities and derivatives, listed in active markets. The Company will not adjust the quoted price for these instruments, even in situations where the Company holds a large position and a sale could reasonably impact the quoted price.

Level 2—inputs to the valuation methodology are quoted prices in markets that are not active or for which all significant inputs are either directly or indirectly observable as of the measurement date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in markets that are not active, and certain over-the-counter derivatives where the fair value is based on observable inputs.

Level 3—inputs to the valuation methodology are unobservable and significant to the overall fair value measurement, and include situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation. The types of financial instruments in this category include investments in privately held entities, non-investment grade residual interests in securitizations and certain over-the-counter derivatives where the fair value is based on unobservable inputs.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the determination of which category within the fair value hierarchy is appropriate for any given financial instrument is based on the lowest level of input that is significant to the fair value measurement. Assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument.

Pursuant to the framework set forth above, the Company values securities traded in active markets on the measurement date by multiplying the exchange closing price of such traded securities/instruments by the quantity of shares or amount of the instrument held. The Company may also obtain quotes with respect to certain of the investments from pricing services, brokers or dealers' quotes, or counterparty marks in order to value liquid assets that are not traded in active markets. Pricing services aggregate, evaluate and report pricing from a variety of sources including observed trades of identical or similar securities, broker or dealer quotes, model-based valuations and internal fundamental analysis and research. When doing so, the Company will determine whether the quote obtained is sufficient according to U.S. GAAP to determine the fair value of the security. If determined adequate, the Company will use the quote obtained.

Securities that are illiquid or for which the pricing source does not provide a valuation or methodology or provides a valuation or methodology that, in the judgment of the Investment Adviser or the Board, does not represent fair value, each is valued as of the measurement date using all techniques appropriate under the circumstances and for which sufficient data is available. These valuation techniques may vary by investment but include comparable public market valuations, comparable precedent transaction valuations and discounted cash flow analyses. The Board undertakes a multi-step valuation process each quarter, as described below:


19

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
(1)each portfolio company or investment is initially valued by the investment professionals responsible for the portfolio investment using a standardized template designed to approximate fair market value based on observable market inputs and updated credit statistics and unobservable inputs;

(2)preliminary valuation conclusions are documented and reviewed by a valuation committee comprised of members of the Investment Adviser's senior management;

(3)the Board engages one independent third-party valuation firm to provide positive assurance on a portion of our illiquid investments each quarter (such that each illiquid investment will be reviewed by an independent valuation firm at least once on a rolling twelve month basis) including review of management's preliminary valuation and conclusion of fair value;

(4)the Audit Committee reviews the assessments of the Investment Adviser and the independent third-party valuation firm and provide the Board with recommendations with respect to the fair value of each investment in our portfolio; and

(5)    the Board discusses the valuation recommendations of the Audit Committee and determine the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser and, where applicable, the third-party valuation firm.

The fair value is generally determined based on the assessment of the following factors, as relevant:
•     the nature and realizable value of any collateral;
•     call features, put features and other relevant terms of debt;
•     the portfolio company's leverage and ability to make payments;
•     the portfolio company's public or "private letter" credit ratings;
•     the portfolio company's actual and expected earnings and cash flow;
•     prevailing interest rates for like securities and expected volatility in future interest rates;
•     the markets in which the issuer does business and recent economic and/or market events; and
•     comparisons to publicly traded securities.

Investment performance data utilized will be the most recently available as of the measurement date which in many cases may reflect up to a one quarter lag in information.

The Board is ultimately responsible for the determination, in good faith, of the fair value of our portfolio investments.

As of September 30, 2020, portfolio investments were transferred into Level 3 from Level 2 at fair value as of the beginning of the period in which the reclassification occurred. For the three and nine months ended September 30, 2020, there were $19,235 and $19,235 of investments transferred into Level 3 from Level 2, respectively.

The following table presents the fair value hierarchy of the investments:
September 30, 2020
Level 1Level 2Level 3Total
First Lien Debt$— $— $322,130 $322,130 
Second Lien Debt— — 14,217 14,217 
Total Investments$ $ $336,347 $336,347 

The following table presents changes in the fair value of the investments for which Level 3 inputs were used to determine the fair value for the three months ended September 30, 2020:


20

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
First Lien DebtSecond Lien DebtTotal Investments
Fair value, beginning of period$160,667 $14,185 $174,852 
Purchases of investments149,390 — 149,390 
Proceeds from principal repayments and sales of investments(11,764)— (11,764)
Accretion of discount/amortization of premium669 678 
Net change in unrealized appreciation (depreciation)3,933 23 3,956 
Net realized gains (losses)— — — 
Transfers into/out of Level 319,235 — 19,235 
Fair value, end of period$322,130 $14,217 $336,347 
Net change in unrealized appreciation (depreciation) from investments still held as of September 30, 2020$3,933 $23 $3,956 

The following table presents changes in the fair value of the investments for which Level 3 inputs were used to determine the fair value for the nine months ended September 30, 2020:
First Lien DebtSecond Lien DebtTotal Investments
Fair value, beginning of period$ $ $ 
Purchases of investments312,637 14,700 327,337 
Proceeds from principal repayments and sales of investments(13,851)— (13,851)
Accretion of discount/amortization of premium1,043 21 1,064 
Net change in unrealized appreciation (depreciation)3,066 (504)2,562 
Net realized gains (losses)— — — 
Transfers into/out of Level 319,235 — 19,235 
Fair value, end of period$322,130 $14,217 $336,347 
Net change in unrealized appreciation (depreciation) from investments still held as of September 30, 2020$2,637 $(504)$2,133 

The following table presents quantitative information about the significant unobservable inputs of the Company’s Level 3 financial instruments. The table is not intended to be all-inclusive but instead captures the significant unobservable inputs relevant to the Company’s determination of fair value.

Range
Fair
Value
Valuation TechniqueUnobservable
Input
LowHighWeighted
Average
Investments in first lien debt$310,390 Yield AnalysisDiscount Rate5.65 %9.30 %7.42 %
11,740 Consensus PricingIndicative Quote$97.94 $97.94 $97.94 
322,130 
Investments in second lien debt14,217 Yield AnalysisDiscount Rate10.63 %10.63 %10.63 %
Total$336,347 


21

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
The significant unobservable inputs used in the fair value measurement of the Company’s investments in first and second lien debt securities are discount rates and indicative quotes. Significant increases in discount rates in isolation would result in a significantly lower fair value measurement. Significant decreases in indicative quotes in isolation would result in a significantly lower fair value measurement.

Financial instruments disclosed but not carried at fair value

The carrying value and fair value of the Company’s secured borrowings disclosed but not carried at fair value as of September 30, 2020 were as follows:

Carrying ValueFair Value
CIBC Subscription Facility$181,350 $181,350 
Total$181,350 $181,350 

The above fair value measurements were based on significant unobservable inputs and thus represent Level 3 measurements as defined under ASC 820.

As of December 31, 2019, the Company had no secured borrowings outstanding.

(6)Debt
On December 31, 2019, the Company entered into a revolving credit agreement (the "CIBC Subscription Facility") with CIBC Bank USA as administrative agent and arranger, which was subsequently amended on February 3, 2020. The maximum principal amount of the CIBC Subscription Facility, which was $100,000 as of December 31, 2019, was increased to $325,000 on February 3, 2020.

The CIBC Subscription Facility allows the Company to borrow up to $325,000 at any one time outstanding, subject to certain restrictions, including availability under the borrowing base, which is based on unused Capital Commitments. The amount of permissible borrowings under the CIBC Subscription Facility may be increased to up to an aggregate amount of $500,000 with the consent of the lenders. The CIBC Subscription Facility has a maturity date of December 31, 2022.

The CIBC Subscription Facility bears interest at a rate at the Company’s election of either (i) the per annum one-, two-, or three-month LIBOR, divided by a number determined by subtracting from 1.00 the then stated maximum reserve percentage for determining reserves to be maintained by member banks of the Federal Reserve System for Eurocurrency funding or liabilities, plus 1.65% or (ii) the prime rate plus 0.65%, as calculated under the CIBC Subscription Facility. The CIBC Subscription Facility is secured by the unfunded commitments of certain stockholders of the Company. The Company has made customary representations and warranties and is required to comply with various covenants, reporting requirements and other customary requirements for similar credit facilities. Borrowings under the CIBC Subscription Facility are subject to the leverage restrictions contained in the 1940 Act.

As of September 30, 2020 and December 31, 2019, the Company was in compliance with all covenants and other requirements of the CIBC Subscription Facility. The summary information of the CIBC Subscription Facility is as follows:

22

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
Three Months
Ended
September 30, 2020
Nine Months
Ended
September 30, 2020
Borrowing interest expense$638 $1,066 
Facility unused commitment fees97 347 
Amortization of financing costs232 637 
Total$967 $2,050 
Weighted average interest rate (excluding unused fees and financing costs)1.84 %1.98 %
Weighted average outstanding balance$135,709 $70,727 

During the three months ended September 30, 2020, the Company borrowed $107,500 and repaid $105,500 under the CIBC Subscription Facility.

During the nine months ended September 30, 2020, the Company borrowed $391,350 and repaid $210,000 under the CIBC Subscription Facility.

As of September 30, 2020, the Company had $181,350 outstanding under the CIBC Subscription Facility. As of December 31, 2019, no borrowings were outstanding under the CIBC Subscription Facility. As of September 30, 2020 and December 31, 2019, the Company had $143,650 and $100,000, respectively, of available capacity under the CIBC Subscription Facility.

(7)Commitments and Contingencies

In the normal course of business, the Company may enter into contracts that provide a variety of general indemnifications. Any exposure to the Company under these arrangements could involve future claims that may be made against the Company. Currently, no such claims exist or are expected to arise and, accordingly, the Company has not accrued any liability in connection with such indemnifications.

As of September 30, 2020, the Company had $156,224 unfunded commitments to fund delayed draw and revolving senior secured loans. As of December 31, 2019, the Company had no unfunded commitments to fund delayed draw and revolving senior secured loans.

A summary of the Company’s contractual payment obligations under the CIBC Subscription Facility as of September 30, 2020 is as follows:

Payments Due by Period
TotalLess
than
1 year
1-3 years3-5
years
After 5
years
CIBC Subscription Facility$181,350 $— $181,350 $— $— 
Total Contractual Obligations$181,350 $ $181,350 $ $ 


As of September 30, 2020 and December 31, 2019, the Company had $1,402,813 and $755,340, respectively, in total capital commitments from stockholders, of which $1,175,407 and $755,340, respectively, were unfunded.

23

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
(8)Net Assets

Pursuant to the BDC Conversion, the Company has the authority to issue 100,000,000 shares of Common Stock at $0.001 par value per share and 1,000,000 shares of preferred stock shares at $0.001 par value per share.

The following table shows the components of distributable earnings as shown on the Consolidated Balance Sheets:

As of
September 30, 2020
As of
December 31, 2019
Undistributed net investment income (loss)$2,770 $(1,156)
Accumulated realized gain (loss)2,154 — 
Net unrealized appreciation (depreciation)2,133 — 
Dividend declared(4,761)— 
Distributable earnings (Accumulated loss)$2,296 $(1,156)

MS Credit Partners Holding, Inc. (“MS Investor”), an affiliate of the Investment Adviser, had made aggregate equity contributions of $35 to the Company as of December 31, 2019. In connection with the Company's conversion to a corporation, on November 25, 2019, the Company issued 1,750 shares of Common Stock to MS Investor for this seed capital investment.

On December 23, 2019, the Company completed its initial closing of Capital Commitments of $755,340 of which $150,000 represents the commitment of MS Investor.

During the three months and nine months ended September 30, 2020, the Company completed one and six closings, respectively. As of September 30, 2020, the Company received aggregate Capital Commitments of $1,402,813, of which $200,000 was from MS Investor. During the nine months ended September 30, 2020, the Company made five capital calls to its stockholders. As a result, the total shares issued and proceeds received related to capital drawdowns delivered pursuant to the Subscription Agreements for the nine months ended September 30, 2020 are set forth below (dollar amounts in millions, unless otherwise noted):

Share Issuance DateShares IssuedAmount
February 5, 20202,874,810$57.50 
March 27, 20202,410,31344.95 
June 26, 2020769,19514.95 
August 11, 20202,002,07139.98 
September 28, 20203,504,63469.99 
Total11,561,023$227.37 

The Company’s weighted average number of shares outstanding from November 25, 2019 to December 31, 2019 and the nine months ended September 30, 2020 were 1,750 and 5,559,741 shares, respectively.

As of September 30, 2020 and December 31, 2019, the Company had $1,402,813 and $755,340, respectively, in total capital commitments from stockholders, of which approximately $1,175,407 and $755,340, respectively, were unfunded.

The following table summarizes the Company's dividends declared and payable for the nine months ended September 30, 2020:

24

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
Date DeclaredRecord DatePayment DatePer Share AmountTotal Amount
June 19, 2020June 19, 2020July 15, 2020$0.29 $1,533 
September 24, 2020September 24, 2020October 22, 20200.40 3,228 
Total Distributions$0.69 $4,761 

(9)Earnings Per Share

    The following table sets forth the computation of basic and diluted earnings per share:

For the three months ended
September 30, 2020
For the nine months ended
September 30, 2020
Numerator for basic and diluted earnings per share - net increase/(decrease) in net assets resulting from operations$6,619 $8,213 
Denominator for basic and diluted earnings per share - weighted average shares outstanding (1)
7,290,085 5,559,741 
Basic and diluted earnings per share$0.91 $1.48 
(1) Calculated for the period from February 5, 2020, the date of first external issuance of shares through September 30, 2020.
(10)Income Taxes

Taxable income during the nine months ended September 30, 2020 differs from net increase (decrease) in net assets resulting from operations primarily due to unrealized appreciation (depreciation) on investments, as gains and losses are generally not included in taxable income until realized.

The Company makes certain adjustments to the classification of net assets as a result of permanent book-to-tax differences, which include differences in the book and tax basis of certain assets and liabilities, and nondeductible federal taxes or losses among other items. To the extent these differences are permanent, they are charged or credited to additional paid in capital, undistributed net investment income or undistributed net realized gains on investments, as appropriate.  For the nine months ended September 30, 2020, there were no material permanent differences.

The cost and unrealized gain (loss) on the Company’s financial instruments, as calculated on a tax basis, at September 30, 2020 are as follows (amounts calculated using book-tax differences as of the most recent fiscal year ended December 31, 2019):

As of September 30, 2020
Gross unrealized appreciation$3,188 
Gross unrealized depreciation(1,055)
Net unrealized appreciation (depreciation)$2,133 
Tax cost of investments at period end$334,214 

(11) Financial Highlights

The Company commenced investing operations on January 31, 2020. Net asset value, at the beginning of period represents the initial offering price per share. The following are the financial highlights (dollar amounts in thousands, except per share data):

25

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
For the nine months
ended September 30, 2020
Per Share Data:(1)
Net asset value, beginning of period$20.00 
Net investment income (loss)
0.71 
Net unrealized and realized gain (loss)(2)
(0.43)
Net increase (decrease) in net assets resulting from operations0.28 
Distributions declared(0.69)
Issuance of common stock0.28 
Total increase (decrease) in net assets(0.13)
Net asset value, end of period$19.87 
Shares outstanding, end of period11,574,440 
Total return based on net asset value(3)
2.78 %
Ratio/Supplemental Data (all amounts in thousands except ratios):
Net assets, end of period$229,929 
Weighted average shares outstanding(4)
5,559,741 
Ratio of net expenses to average net assets(5)
6.50 %
Ratio of expenses before waivers to average net assets(5)
7.48 %
Ratio of net investment income to average net assets(5)
4.82 %
Total capital commitments, end of period$1,402,813 
Ratios of total contributed capital to total committed capital, end of period16.21 %
Asset coverage ratio226.79 %
Portfolio turnover rate24.56 %
(1)The per share data was derived by using the weighted average shares outstanding during the period.
(2)For the nine months ended September 30, 2020, the amount shown does not correspond with the aggregate amount for the period as it includes the effect of the timing of capital transactions.
(3)Total return (not annualized) is calculated as the change in net asset value per share during the period, plus distributions per share (assuming dividends and distributions are reinvested in accordance with the Company's dividend reinvestment plan) divided by the beginning net asset value per share. Because the Company commenced investing operations at the end of January 2020, the total return for the nine months ended September 30, 2020, is not indicative of the actual performance. Excluding the effects of the offering price of subscriptions in excess of net asset value per share, total return (not annualized) would have been 1.38%.
(4)Calculated for the period from February 5, 2020, the date of first external issuance of shares through September 30, 2020.
(5)Amounts are annualized except for incentive fees, and expense support amounts relating to organizational and offering costs.


26

Morgan Stanley Direct Lending Fund
Notes to Consolidated Financial Statements (Unaudited)
September 30, 2020
(In thousands, except shares and per share data)
(12) Subsequent Events

Subsequent events have been evaluated through the date the consolidated financial statements were issued. There have been no subsequent events that require recognition or disclosure through the date the consolidated financial statements were issued, except as disclosed below.
On October 12, 2020, the Company closed new investor commitments of $13,400, which brings total Capital Commitments to approximately $1,416,213.
On October 14, 2020, DLF LLC entered into a Revolving Credit and Security Agreement (the "Credit and Security Agreement") with DLF LLC, as the borrower, BNP Paribas ("BNP"), as the administrative agent and lender, the Company, as the equityholder and as the servicer, and U.S. Bank National Association, as collateral agent, pursuant to which BNP has agreed to extend credit to DLF LLC in an aggregate principal amount up to $300 million at any one time outstanding (the "BNP Funding Facility").
The BNP Funding Facility is a revolving funding facility with a reinvestment period ending October 13, 2023 and a final maturity date of October 13, 2025. Subject to certain conditions, the reinvestment period and final maturity are both subject to a one-year extension. Advances under the BNP Funding Facility are available in U.S. dollars, pound sterling, Euro or Canadian dollars, and subject to certain exceptions, the interest charged on the BNP Funding Facility is based on LIBOR (Dollar), LIBOR (GBP), EURIBOR or CDOR, as applicable (or, if LIBOR (Dollar) is not available, a benchmark replacement or a “base rate” (which is the greater of a prime rate and the federal funds rate plus 0.50%), as applicable), plus a margin that generally ranges between 2.25% and 3.25% (depending on the types of assets such advances relate to), with a weighted average margin floor for all classes of advances of (i) 2.80% during the reinvestment period and (ii) 3.30% following the reinvestment period, with specific margins for non-U.S. dollar advances as set forth in the Credit and Security Agreement.
The obligations of DLF LLC under the BNP Funding Facility are secured by all of the assets held by DLF LLC, including
certain loans to be sold or transferred by the Company to DLF LLC pursuant to the terms of the Purchase and Sale Agreement (the
“Purchase and Sale Agreement” and, together with the Credit and Security Agreement, the “Agreements”) between the Company and
DLF LLC entered into in connection with the BNP Funding Facility, pursuant to which the Company will sell to DLF LLC certain
loans it has originated or acquired, or will originate or acquire (the “Loans”) from time to time. Under the Agreements, the Company
and DLF LLC, as applicable, have made representations and warranties regarding the Loans, as well as their businesses, and are
required to comply with various covenants, servicing procedures, limitations on disposition of Loans, reporting requirements and
other customary requirements for similar revolving funding facilities. The Credit and Security Agreement includes usual and
customary events of default for revolving funding facilities of this nature, including allowing BNP, upon a default, to accelerate and
foreclose on the Loans and to pursue the rights under the Loans directly with the obligors thereof. In connection with the entry into
the BNP Funding Facility, DLF LLC also entered into various supporting documentation, including an account control agreement.

Borrowings under the BNP Funding Facility are subject to various covenants under the Agreements as well as the leverage
restrictions contained in the 1940 Act.

27


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

In this Quarterly Report on Form 10-Q, or this “Report”, except where context suggests otherwise, the terms
"Company," "we," "our" or "us" refers to Morgan Stanley Direct Lending Fund and its consolidated subsidiaries. This Report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about us, our current and prospective portfolio investments, our industry, our beliefs and our assumptions. Words such as "anticipates," "expects," "intends," "plans," "will," "may," "continue," "believes," "seeks," "estimates," "would," "could," "should," "targets," "projects," and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including:

our future operating results;
our business prospects and the prospects of our portfolio companies;
risk associated with possible disruptions in our operations or the economy generally, including disruptions from the impact of the current Coronavirus (also referred to as “COVID-19” or “Coronavirus”) pandemic;
general economic, political and industry trends and other external factors, including uncertainty surrounding the financial and political stability of the United States, the United Kingdom, the European Union and China;
our contractual arrangements and relationships with third parties;
actual and potential conflicts of interest with MS Capital Partners Adviser Inc., our investment adviser, or the Investment Adviser, and its affiliates;
the dependence of our future success on the general economy and its effect on the industries in which we invest;
the ability of our portfolio companies to achieve their objectives, including as a result of the Coronavirus pandemic;
the use of borrowed money to finance a portion of our investments;
the adequacy of our financing sources and working capital;
the timing of cash flows, if any, from the operations of our portfolio companies;
the ability of our Investment Adviser to locate suitable investments for us and to monitor and administer our investments;
the ability of our Investment Adviser and its affiliates to attract and retain highly talented professionals;
our ability to qualify and maintain our qualification as a business development company, or a BDC, and as a regulated investment company, or a RIC, under the Internal Revenue Code of 1986, as amended, or the Code;
the effect of changes in tax laws and regulations and interpretations thereof; and
the risks, uncertainties and other factors we identify under "Item 1A. Risk Factors" and elsewhere in this Report.

The information contained in this section should be read in conjunction with “Item 1. Consolidated Financial Statements.”. Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of the assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this Report should not be regarded as a representation by us that our plans and objectives will be achieved.   This discussion contains forward-looking statements, which relate to future events or our future performance or financial condition and involves numerous risks and uncertainties, including, but not limited to, those set forth in “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019, or the Form 10-K, and Part II, Item 1A of and elsewhere in this Report. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Report. You are advised to consult any additional disclosures that we make directly to you or through reports that we have filed or in the future file with the Securities and Exchange Commission, or the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

You should understand that under Section 27A(b)(2)(B) of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E(b)(2)(B) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, the “safe harbor” provisions of the

28

Private Securities Litigation Reform Act of 1995 do not apply to forward-looking statements made in periodic reports we file under the Exchange Act.
29

OVERVIEW
We are an externally managed specialty finance company focused on lending to middle market companies that has elected to be regulated as a BDC. Our investment objective is to achieve attractive risk-adjusted returns via current income and, to a lesser extent, capital appreciation by investing primarily in directly originated senior secured term loans issued by U.S. middle market companies backed by financial sponsors. For the purposes of this Report, "middle-market companies" refers to companies that, in general, generate annual earnings before interest, taxes, depreciation and amortization in the range of approximately $15 million to $100 million, which we believe is a useful proxy for cash flow.
We intend to achieve our investment objective by investing primarily in directly originated senior secured term loans including first lien senior secured term loans (including unitranche loans) and second lien senior secured term loans, with the balance of our investments expected to be in higher-yielding assets such as mezzanine debt, unsecured debt, equity investments and other opportunistic assets. Typical middle market senior loans may be issued by middle market companies in the context of leveraged buyouts, acquisitions, debt refinancings, recapitalizations, and other similar transactions.
We expect to generate revenues primarily in the form of interest income from investments we hold. In addition, we expect to generate income from dividends on any direct equity investments, capital gains on the sales of loans and debt and equity investments and various other loan origination and other fees.
On September 18, 2020, the SEC granted us exemptive relief (the “Order”) that allows us to enter into certain negotiated co-investment transactions alongside certain Affiliated Investment Accounts (as defined in the Order) in a manner consistent with our investment objective, positions, policies, strategies, and restrictions as well as regulatory requirements and other pertinent factors,subject to compliance with the Order. Pursuant to the Order, we are permitted to co-invest with our affiliates if a “required majority” (as defined in Section 57(o) of the 1940 Act) of our eligible directors make certain conclusions in connection with a co-investment transaction, including that (1) the terms of the transactions, including the consideration to be paid, are reasonable and fair to us and our stockholders and do not involve overreaching in respect of us or our stockholders on the part of any person concerned, and (2) the transaction is consistent with the interests of our stockholders and is consistent with our investment objective and strategies.
For a discussion of the competitive landscape we face, please see “Item 1A. Risk Factors–Risks Relating to Our Business and Structure” in the Form 10-K and “Item 1A. Risk Factors” in this Report.
Coronavirus Developments

The rapid spread of Coronavirus and the related effect on the U.S. and world economy has had and will likely continue to have adverse consequences for the business operations of some of our portfolio companies and may adversely affect our operations and the operations of our Investment Adviser (including those relating to us). Our Investment Adviser has been monitoring the Coronavirus pandemic and its impact on our business and the business of our portfolio companies and has been focused on proactively engaging with our portfolio companies in order to collaborate with the management teams of certain portfolio companies to assess and evaluate the steps each portfolio company can take in response to the impacts of Coronavirus.

Despite the market dislocation cause by Coronavirus, we believe we are very well positioned to manage the current environment. Unlike many direct lending vehicles, prior to the spread of the Coronavirus pandemic, we did not have a large legacy portfolio that may suffer from weak economic conditions due to the impact of Coronavirus. Secondly, we have a considerable amount of available capital that can be prudently invested in a credit environment that we expect will provide better risk adjusted returns than before the market dislocation caused by Coronavirus. Capital preservation and principal protection are among the key tenets of what we seek to achieve with our investment strategy. We will deploy capital as we find what we believe are compelling investment opportunities, and we intend to invest our capital throughout our three-year investment period, providing our investors with vintage year diversification.

Prior to Coronavirus having a significant impact on the U.S. capital markets, we had funded approximately $93 million of investments and benefited from having very limited unfunded exposure of only $8 million (revolvers and delayed draw term loans) associated with these investments. Multiple stresses since the onset of the Coronavirus pandemic have led to steep dislocations in both the debt and equity markets. While we have seen a sharp recovery across asset classes, significant volatility and uncertainty remain,
30

including uncertainty relating to another wave of Coronavirus in the United States and globally, domestic unrest, tension with China and the uncertainty relating to the results of the U.S. elections. We believe that these factors have created stress on the market and while we have seen a tightening of spreads this quarter over the previous one, we believe that the current private credit market opportunities will be more favorable for lenders than before the market dislocation, which could be reflected by lower leverage multiples, higher yields and stronger loan documentation and covenants.

During the three months ended September 30, 2020, we made new investment commitments of approximately $284.0 million and new investment fundings of approximately $149.4 million. New investment commitments were made across ten portfolio companies and were comprised of 100% first lien debt. During the three months ended September 30, 2020, we sold approximately $11.3 million of investments, taking advantage of the market dislocation, and realized gains of approximately $0.8 million.

As of September 30, 2020, each of our investments is a senior secured credit facility (95.8% first lien and 4.2% second lien at fair value) with substantial private equity capital junior to our loan investments, providing what we believe is meaningful downside protection. Our investment strategy is predicated on seeking to lend to companies in non-cyclical industry sectors (typically avoiding sectors such as retail, restaurants, and energy) with proven management teams. Additionally, we continue to have no exposure to the airlines, lodging and leisure sectors, which we expect will continue to be among the most impacted by Coronavirus.

We are well capitalized as of September 30, 2020, with over $1.3 billion of available capital (approximately $1.2 billion of available uncalled equity and approximately $144 million of available capacity under our revolving credit agreement, as amended, or, the CIBC Subscription Facility, with CIBC Bank USA, as administrative agent and arranger, entered into on December 31, 2019 and subsequently amended on February 3, 2020). As of September 30, 2020, we have called $227,406 of the total committed equity capital. We believe our strong capital base positions us extremely well to invest over the near term and throughout our investment period when we identify opportunities that we believe offer compelling value. Conducting detailed due diligence is central to our investment strategy and we will continue to seek to build a highly diversified portfolio of predominantly first lien senior secured term loans, avoid the more cyclical industry sectors, and fully leverage the vast origination and due diligence resources of Morgan Stanley.

However, we cannot predict the full impact of the Coronavirus pandemic, including its duration in the United States and worldwide and the magnitude of the economic impact of the outbreak, including with respect to the travel restrictions, business closures and other quarantine measures imposed on service providers and other individuals by various local, state, and federal governmental authorities, as well as non-U.S. governmental authorities, especially in light of the uncertainty surrounding another
wave of the virus. As such, the extent to which Coronavirus and/or other health pandemics may negatively affect our and our portfolio companies’ operating results and financial condition, or the duration of any potential business or supply-chain disruption for us, our Investment Adviser and/or our portfolio companies, is uncertain. Depending on the duration and extent of the disruption to the operations of our portfolio companies, certain portfolio companies may experience financial distress and possibly default on their financial obligations to us and their other capital providers. Some of our portfolio companies may significantly curtail business operations, furlough or lay off employees and terminate service providers, and defer capital expenditures if subjected to prolonged and severe financial distress, which would likely impair their business on a permanent basis. These developments would likely result in a decrease in the value of our investment in any such portfolio company.

We are also subject to financial risks, including changes in market interest rates. As of September 30, 2020, all of our debt investments at fair value were at floating rates, based on the London Interbank Offered Rate, or LIBOR, and many of which are subject to certain floors. In addition, the CIBC Subscription Facility has floating rate interest provisions. In connection with the Coronavirus pandemic, the U.S. Federal Reserve and other central banks have reduced certain interest rates and LIBOR has decreased. A prolonged reduction in interest rates could reduce our expected gross investment income and could result in a decrease in our expected net investment income if decreases in LIBOR are not offset by a corresponding increase in the spread over LIBOR that we earn on any portfolio investments, a decrease in our operating expenses, including with respect to our income based incentive fee, or a decrease in the interest rate of any floating interest rate liabilities we may have that are tied to LIBOR. See “Item 3. Quantitative and Qualitative Disclosures About Market Risk” for an analysis of the impact of hypothetical base rate changes in interest rates.

We will continue to monitor the rapidly evolving situation relating to the Coronavirus pandemic and guidance from U.S. and international authorities, including federal, state and local public health authorities and may take additional actions based on their recommendations. In these circumstances, there may be developments outside our control requiring us to adjust our plan of operation. As such, given the dynamic nature of this situation, we cannot reasonably estimate the impacts of Coronavirus on our financial condition, results of operations or cash flows in the future.
31


Investment Strategy

Our primary investment strategy is to make privately negotiated senior secured credit investments in U.S. middle market companies that have leading market positions, enjoy high barriers to entry, generate strong and stable free cash flow and are led by proven management teams with strong financial sponsor backing. Our investment approach is focused on long term credit performance, risk mitigation and preservation of capital. Our Investment Adviser employs a highly rigorous, fundamentals driven and disciplined investment process developed and refined by the investment professionals of the Private Credit platform. The Investment Team works on a particular transaction from origination to close and continues to monitor each investment throughout its life cycle.

We seek to invest primarily in companies backed by leading private equity sponsors with strong track records. We believe lending to sponsor-backed companies (versus non-sponsor-backed companies) has many distinct potential advantages including:
Strong, predictable deal flow given significant private equity committed capital;
Well-capitalized borrowers, including access to additional capital from sponsors, if needed;
Access to detailed financial, operational, industry data, and third-party legal and accounting due diligence reports conducted by the sponsor as part of their due diligence;
Proper oversight and governance provided by a board of directors, coupled with industry and/or operating expertise;
Natural alignment of interests between lender and sponsor given focus on exit strategy; and
Supplemental diligence beyond the credit analysis of the borrower, given the ability to analyze track records of each private equity firm.

We intend to create a well-diversified, defensive portfolio of investments focusing on generally avoiding issuer or industry concentration in order to mitigate risk and achieve our investment objective. We intend to primarily focus on U.S. middle market companies. However, to the extent that we invest in foreign companies, we intend to do so in accordance with the limitations under the Investment Company Act of 1940, or the 1940 Act, and only in jurisdictions with established legal frameworks and a history of respecting creditor rights, including the United Kingdom and countries that are members of the European Union, as well as Canada, Australia and Japan. Our investment strategy is predicated on seeking to lend to companies in non-cyclical industry sectors (typically avoiding sectors such as retail, restaurants, energy, alcohol, tobacco, pork manufacturing, gaming and gambling, and pornography) with proven management teams.
KEY COMPONENTS OF OUR RESULTS OF OPERATIONS
Investments
Our level of investment activity can and does vary substantially from period to period depending on many factors, including the amount of debt available to middle market companies, the general economic environment and the competitive environment for the type of investments we make.
Revenue
We expect to generate revenue primarily in the form of interest income on debt investments we hold. In addition, we expect to generate income from dividends on direct equity investments, capital gains on the sales of loans and debt and equity securities and various loan origination and other fees. Our debt investments generally have a stated term of five to eight years and generally bear interest at a floating rate usually determined on the basis of a benchmark such as LIBOR. Interest on these debt investments is generally paid quarterly. In some instances, we receive payments on our debt investments based on scheduled amortization of the outstanding balances. In addition, we receive repayments of some of our debt investments prior to their scheduled maturity date. The frequency or volume of these repayments fluctuates significantly from period to period and may be influenced by market and economic conditions, including as a result of the current Coronavirus pandemic. See "Coronavirus Developments" above. Our portfolio activity also reflects the proceeds of sales of securities. We may also generate revenue in the form of commitment, origination, amendment, structuring or due diligence fees, fees for providing managerial assistance and consulting fees.
Expenses
Our primary operating expenses include the payment of: (i) investment advisory fees, including base management fees and incentive fees, to our Investment Adviser pursuant to an investment advisory agreement entered into between us and our Investment Adviser, or the Investment Advisory Agreement; (ii) costs and other expenses and our allocable portion of overhead incurred by MS
32

BDC Administrative Services LLC, an affiliate of the our Investment Adviser, or the Administrator, in performing its administrative obligations pursuant to an administration agreement between us and our Administrator, or the Administration Agreement; and (iii) other operating expenses as detailed below:
initial organization costs and offering costs incurred prior to the filing of our election to be regulated as a BDC (subject to the expense waiver described below)
costs associated with our initial private offering;
costs of any other offerings of our common stock, par value $0.001 per share, or the Common Stock, and other securities, if any;
calculating individual asset values and our net asset value (including the cost and expenses of any third-party valuation services);
out of pocket expenses, including travel expenses, incurred by the Investment Adviser, or members of its investment team or payable to third parties, performing due diligence on prospective portfolio companies and monitoring actual portfolio companies and, if necessary, enforcing the rights;
base management fee and any incentive fee payable under the Investment Advisory Agreement;
certain costs and expenses relating to distributions paid by us;
administration fees payable under the Administration Agreement and any sub-administration agreements, including related expenses;
debt service and other costs of borrowings or other financing arrangements;
the allocated costs incurred by the Investment Adviser in providing managerial assistance to those portfolio companies that request it;
amounts payable to third parties relating to, or associated with, making or holding investments;
the costs associated with subscriptions to data service, research-related subscriptions and expenses and quotation equipment and services used in making or holding investments;
transfer agent and custodial fees;
costs of hedging;
commissions and other compensation payable to brokers or dealers;
any stock exchange listing fees and fees payable to rating agencies;
cost of effecting any sales and repurchases of our Common Stock and other securities;
federal and state registration fees;
U.S. federal, state and local taxes, including any excise taxes;
independent director fees and expenses;
costs of preparing financial statements and maintaining books and records, costs of preparing tax returns, costs of Sarbanes-Oxley Act compliance and attestation and costs of filing reports or other documents with the U.S Securities and Exchange Commission (or other regulatory bodies), and other reporting and compliance costs, including registration and listing fees, and the compensation of professionals responsible for the preparation or review of the foregoing;
the costs of any reports, proxy statements or other notices to our stockholders (including printing and mailing costs), the costs of any stockholders’ meetings and the compensation of investor relations personnel responsible for the preparation of the foregoing and related matters;
the costs of specialty and custom software for monitoring risk, compliance and overall investments;
our fidelity bond;
any necessary insurance premiums;
indemnification payments;
any extraordinary expenses (such as litigation or indemnification payments or amounts payable pursuant to any agreement to provide indemnification entered into by us);
direct fees and expenses associated with independent audits, agency, consulting and legal costs;
33

cost of winding up; and
all other expenses incurred by either the Administrator or us in connection with administering our business, including payments under the Administration Agreement based upon our allocable portion of the compensation paid to our Chief Financial Officer and Chief Compliance Officer and reimbursing third-party expenses incurred by the Administrator in carrying out its administrative services including, but not limited to, the fees and expenses associated with performing compliance functions.
We expect our general and administrative expenses to be relatively stable or to decline as a percentage of total assets during periods of asset growth and to increase during periods of asset declines.

34

PORTFOLIO AND INVESTMENT ACTIVITY
As noted above in “Coronavirus Developments,” we believe that our portfolio and investment strategy is well positioned to weather the current market environment. We believe the following factors will mitigate the economic impact of Coronavirus on our portfolio and on our portfolio companies:

Senior Investments: As of September 30, 2020, each of our investments is a senior secured credit facility (95.8% first lien and 4.2% second lien at fair value) with substantial private equity capital junior to our loan investments, providing what we believe is meaningful downside protection. As of September 30, 2020, we had unfunded commitments of $156,224 (revolvers and delayed draw term loans) associated with our debt investments.

Limited Pre-COVID-19 Investment Activity: We do not have a large legacy portfolio that may compound the economic risk of the Coronavirus pandemic. We began investing earlier this fiscal year, and our exposure prior to the market dislocation caused by Coronavirus was limited to five portfolio companies for a total of $93 million. Each of these investments is a senior secured credit facility with substantial private equity capital junior to our loan investments, providing what we believe to be meaningful downside protection.

Industry Exposure: Our investment strategy is predicated on seeking to lend to companies in non-cyclical industry sectors with proven management teams and generally avoiding sectors that are severely impacted by the Coronavirus pandemic. We currently have no exposure to the airlines, lodging and leisure sectors, which we expect will be among the most impacted by Coronavirus.

As of September 30, 2020, we had investments in nineteen portfolio companies across ten industries. Based on fair value as of September 30, 2020, 100% of our debt portfolio was invested in debt bearing a floating interest rate, which primarily are subject to interest rate floors. Approximately 91.3% of our debt investments at fair value had a LIBOR floor. The weighted average LIBOR floor across our debt investments was approximately 1.0% as of September 30, 2020. These floors allow us to mitigate (to a degree) the impact of spread widening on the valuation of our investments. As of September 30, 2020, our weighted average total yield of debt securities at amortized cost was 7.6%. Weighted average yields include the effect of accretion of discounts and amortization of premiums and are based on interest rates as of September 30, 2020.
As of December 31, 2019, we had no investments.     
Our investment activity for the three months ended September 30, 2020 is presented below (information presented herein is at amortized cost unless otherwise indicated):
35

As of and for the Three Months Ended September 30, 2020
New Investments Committed/Purchased
Gross Principal Balance$283,962 
Investments, at Cost
Investments, beginning of period$206,367 
New investments purchased149,390 
Net accretion of discount on investments734 
Net realized gain (loss) on investments791 
Investments sold or repaid(23,068)
Investments, end of period$334,214 
Amount of investments funded at principal
First lien debt investments$149,390 
Second lien debt investments— 
Total$149,390 
Proceeds from investments sold or repaid:
First lien debt investments$23,068 
Second lien debt investments— 
Total$23,068 
Weighted average yield on debt investments, at cost(1)
7.6 %
Weighted average yield on debt investments, at fair value(1)
7.6 %
Number of portfolio companies19 
Percentage of debt investments bearing a floating rate100%
Percentage of debt investments bearing a fixed rate— %
(1)Computed as (a) the annual stated spread, plus applicable Prime/LIBOR or Floor, as applicable, plus the annual accretion of discounts, as applicable, on accruing debt securities, divided by (b) total first lien and second lien debt (at fair value or cost, as applicable) included in such securities. Actual yields earned over the life of each investment could differ materially from the yields presented herein.
As part of the monitoring process, our Investment Adviser has developed risk policies pursuant to which it regularly assesses the risk profile of each of our debt investments. Our Investment Adviser has developed a classification system to group investments into four categories. The investments are evaluated regularly and assigned a category based on certain credit metrics. Please see below for a description of the four categories of the Investment Adviser's Internal Risk Rating system:
36

Category 1In the opinion of our Investment Adviser, investments in Category 1 involve the least amount of risk relative to our initial cost basis at the time of origination or acquisition. Category 1 investments performance is above our initial underwriting expectations and the business trends and risk factors are generally favorable, which may include the performance of the portfolio company, or the likelihood of a potential exit.
Category 2In the opinion of our Investment Adviser, investments in Category 2 involve a level of risk relative to our initial cost basis at the time of origination or acquisition. Category 2 investments are generally performing in line with our initial underwriting expectations and risk factors to ultimately recoup the cost of our principal investment are neutral to favorable. All new originated or acquired investments are initially included in Category 2.
Category 3In the opinion of our Investment Adviser, investments in Category 3 indicate that the risk to our ability to recoup the initial cost basis at the time of origination or acquisition has increased materially since the origination or acquisition of the investment, such as declining financial performance, non-compliance with debt covenants; however principal and interest payments are not more than 120 days past due.
Category 4In the opinion of our Investment Adviser, investments in Category 4 involve a borrower performing substantially below expectations and indicate that the loan's risk has increased substantially since origination or acquisition. Most or all of the debt covenants are out of compliance and payments are substantially delinquent. For Category 4 investments, it is anticipated that we will not recoup our initial cost basis and may realize a substantial loss of our initial cost basis at the time of origination or acquisition upon exit.
As of September 30, 2020, all of our investments had Internal Risk Rating of 2 and were performing in line with our initial underwriting expectations. 
CONSOLIDATED RESULTS OF OPERATIONS
We were formed on May 30, 2019 and commenced our investing operations on January 31, 2020. The following table represents the operating results (dollar amounts in thousands):

 
Three Months Ended September 30, 2020
Three Months Ended September 30, 2019
Nine
months ended
September 30, 2020
May 30, 2019 (inception) to
September 30, 2019
Total investment income$5,659 $— $10,472 $— 
Less: Net expenses3,811 278 6,546 584 
Net investment income1,848 (278)3,926 (584)
Net change in unrealized appreciation (depreciation)3,982 — 2,133 — 
Net realized gain (loss)789 — 2,154 — 
Net increase (decrease) in net assets resulting from operations$6,619 $(278)$8,213 $(584)

Investment Income

Investment income was as follows (dollar amounts in thousands):

    
37

 
Three Months Ended September 30, 2020
Nine Months Ended September 30, 2020
Investment income:
Interest income$5,473 $9,332 
Other income186 1,140 
Total investment income$5,659 $10,472 

For the three and nine months ended September 30, 2020, total investment income was driven by our deployment of capital and invested balance of investments.  The size of our investment portfolio at fair value increased to $336.3 million at September 30, 2020 and all investments were income producing senior secured debt investments.  

Interest income on our first and second lien debt investments is dependent on the composition and credit quality of the portfolio. Generally, we expect the portfolio to generate predictable quarterly interest income based on the terms stated in each loan’s credit agreement. As of September 30, 2020, and for the period then ended, all of our first and second lien debt investments were performing and current on their interest payments.
Expenses

Expenses were as follows (dollar amounts in thousands):
Three Months Ended
September 30, 2020
Three Months Ended September 30, 2019
Nine Months Ended
September 30, 2020
From May 30, 2019 (inception) to September 30, 2019
Interest expense$967 $— $2,050 $— 
Organization and offering costs206 278 541 584 
Professional fees715 — 1,339 — 
Directors' fees87 — 261 — 
Management fees637 — 1,059 — 
Income based incentive fees551 — 969 — 
Capital gain incentive fees750 — 750 — 
Administrative service fees 54 — 140 — 
General and other expenses327 — 369 — 
Total expenses4,294 278 7,478 584 
Expense waiver (5)— (138)— 
Management fees waiver(478)— (794)— 
Net expenses$3,811 $278 $6,546 $584 
For the three months ended September 30, 2020, net expenses were primarily comprised of interest expense of $967, gross base management fees of $637, income based incentive fees of $551, capital gain incentive fees of $750, administrative service expenses of $54, professional fees of $715, fees to independent directors of $87, organization and offering costs of $206 and other expenses of $327; offset by management fee waiver and expense waiver by the Investment Adviser of $478 and $5, respectively.
For the nine months ended September 30, 2020, net expenses were primarily comprised of interest expense of $2,050, gross base management fees of $1,059, income based incentive fees of $969, capital gain incentive fees of $750, administrative service expenses of $140, professional fees of $1,339, fees to independent directors of $261, organization and offering costs of $541 and other expenses of $369; offset by management fee waiver and expense waiver by the Investment Adviser of $794 and $138, respectively.
For the three months ended September 30, 2019 and from May 30, 2019 (inception) to September 30, 2019, net expenses were comprised of organization cost of $278 and $584, respectively.
38

Interest expense for the three and nine months ended September 30, 2020 was driven by approximately $135.7 and $70.7 million of average borrowings, respectively (at an average effective interest rate, of 1.84% and 1.98%, respectively), under our CIBC Subscription Facility related to borrowings for investments and expenses.
Professional fees include legal, audit, tax, valuation, and other professional fees incurred related to the management of us. Administrative service fees represent fees paid to the Administrator for our allocable portion of the cost of certain of our executive officers that perform duties for us. Other general and administrative expenses include insurance, filing, research, subscriptions and other costs. Organization costs and offering costs include expenses incurred in our initial formation and our offering of stock. Expense support includes the management fee waiver of $794 and excess organization and offering costs of $217 that the Investment Adviser has committed to pay at September 30, 2020. Excess organization and offering costs are subject to reimbursement to the Investment Adviser at a future date. See "Item 1. Consolidated Financial Statements—Notes to Consolidated Financial Statements—Note 3."

Income Taxes, Including Excise Taxes
We intend to elect to be treated as a RIC under Subchapter M of the Code, and we intend to operate in a manner so as to continue to qualify for the tax treatment applicable to RICs. To qualify for tax treatment as a RIC, we must, among other things, distribute to our stockholders in each taxable year generally at least 90% of the sum of our investment company taxable income, as defined by the Code (without regard to the deduction for dividends paid), and net tax-exempt income for that taxable year. To maintain our tax treatment as a RIC, we, among other things, intend to make the requisite distributions to our stockholders, which generally relieve us from corporate-level U.S. federal income taxes.

Net Realized Gain (Loss) and Unrealized Gain (Loss) on Investments
 For the three and nine months ended September 30, 2020, net realized gain (losses) on our investments were $0.8 million and $2.2 million, respectively. For the three months ended September 30, 2020, we fully realized our investments in two portfolio companies for gross proceeds of $11.3 million.
We determine the fair value of our portfolio investments quarterly and any changes in fair value are recorded as unrealized gains or losses.  For the three and nine months ended September 30, 2020, net change in unrealized gain (losses) on our investments were $4.0 million and $2.1 million, respectively.

During the three and nine months ended September 30, 2020, the valuations of our debt investments generally increased as a result of the tightening credit spread environment and positive change in the broadly syndicated loan market during the period.

For the three months ended September 30, 2019 and from May 30, 2019 (inception) to September 30, 2019, there were no realized gains/losses or changes in unrealized gains/losses on investments since the Company only commenced operations in January, 2020.

39

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES
This “Financial Condition, Liquidity and Capital Resources” section should be read in conjunction with the “—Coronavirus Developments” section above.
We generate cash from the net proceeds of offerings of our Common Stock and through cash flows from operations, including investment sales and repayments as well as income earned on investments and cash equivalents. We may also fund a portion of our investments through borrowings under the CIBC Subscription Facility and any additional senior secured credit facilities, as well as through securitization of a portion of our existing investments.
As of September 30, 2020, we are party to the CIBC Subscription Facility, as described in “—Debt” below. 
As of September 30, 2020, we had approximately $113 million of Cash, which taken together with our approximately $144 million of availability under the CIBC Subscription Facility (subject to borrowing base availability) and our approximately $1,175 million of uncalled capital commitments to purchase shares of Common Stock, or Capital Commitments, we expect to be sufficient for our investing activities and to conduct our operations in the near term.
Equity
As of September 30, 2020, we had received aggregate Capital Commitments of approximately $1,403 million, of which $200 million was from an affiliate of the Investment Adviser.
During the nine months ended September 30, 2020, we issued five capital calls to our stockholders. As a result, the total shares issued and proceeds received related to capital drawdowns delivered pursuant to the Subscription Agreements for the nine months ended September 30, 2020 were:
Share Issuance DateShares IssuedAmount
February 5, 20202,874,810$57.50 
March 27, 20202,410,31344.95 
June 26, 2020769,19514.95 
August 11, 20202,002,07139.98 
September 28, 20203,504,63469.99 
Total11,561,023$227.37 

Distributions and Dividend Reinvestment
The following table summarizes our distributions declared and payable for the nine months ended September 30, 2020:
Date DeclaredRecord DatePayment DatePer Share AmountTotal Amount
June 19, 2020June 19, 2020July 15, 2020$0.29 $1,533 
September 24, 2020September 24, 2020October 22, 20200.40 3,228 
Total Distributions$0.69 $4,761 

We adopted an “opt in” dividend reinvestment plan (“DRIP”). As a result, our stockholders who elect to “opt in” to the DRIP will have their cash dividends or distributions automatically reinvested in additional shares of Common Stock, rather than receiving cash. Stockholders who receive distributions in the form of shares of Common Stock will generally be subject to the same U.S. federal, state and local tax consequences as if they received cash distributions; however, those stockholders will not receive cash with which to pay any applicable taxes. Shares issued under the DRIP will not reduce an investor’s outstanding Capital Commitment.

40

Debt
CIBC Subscription Facility
On December 31, 2019, we entered into the CIBC Subscription Facility with CIBC Bank USA as administrative agent and arranger. On February 3, 2020, we amended the CIBC Subscription Facility by increasing the total commitment amount by $225 million. As of September 30, 2020, the CIBC Subscription Facility allows us to borrow up to $325 million at any one time outstanding, subject to certain restrictions, including availability under the borrowing base, which is based on unused Capital Commitments.
The amount of permissible borrowings under the CIBC Subscription Facility may be increased to up to an aggregate amount of $500 million with the consent of the lenders. The CIBC Subscription Facility has a maturity date of December 31, 2022.
The CIBC Subscription Facility bears interest at a rate at our election of either (i) the per annum one-, two-, or three-month LIBOR, divided by a number determined by subtracting from 1.00 the then stated maximum reserve percentage for determining reserves to be maintained by member banks of the Federal Reserve System for Eurocurrency funding or liabilities, plus 1.65% or (ii) the prime rate plus 0.65%, as calculated under the CIBC Subscription Facility. The CIBC Subscription Facility is secured by the unfunded commitments of certain of our investors. We have made customary representations and warranties and are required to comply with various covenants, reporting requirements and other customary requirements for similar credit facilities. Borrowings under the CIBC Subscription Facility are subject to the leverage restrictions contained in the 1940 Act, as amended, or the 1940 Act.
During the three and nine months ended September 30, 2020, we borrowed $107.5 million and $391.4 million, respectively, and repaid $105.5 million and $210.0 million, respectively under the CIBC Subscription Facility. As of September 30, 2020, we had $181.4 million outstanding under the CIBC Subscription Facility. As of December 31, 2019, we had no amount borrowed under the CIBC Subscription Facility. As of September 30, 2020 and December 31, 2019 we had $143.7 million and $100.0 million, respectively, of available capacity under the CIBC Subscription Facility.
As of September 30, 2020 and December 31, 2019, we were in compliance with all covenants and other requirements of the CIBC Subscription Facility.
OFF BALANCE SHEET ARRANGEMENTS
In the ordinary course of our business, we enter into contracts or agreements that contain indemnifications or warranties. Future events could occur which may give rise to liabilities arising from these provisions against us. We believe that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in our financial statements as of September 30, 2020 in Part I, Item 1 of this Report for any such exposure.
We have in the past and may in the future become obligated to fund commitments such as revolving credit facilities, bridge financing commitments, or delayed draw commitments. As of September 30, 2020 we had delayed draw terms loans and revolving term loans with an aggregate $156.2 million of unfunded commitments.
Other Commitments and Contingencies
From time to time, we may become a party to certain legal proceedings incidental to the normal course of our business. At September 30, 2020 management is not aware of any material pending or threatened litigation relating to us.
CONTRACTUAL OBLIGATIONS
A summary of our contractual payment obligations under our CIBC Subscription Facility as of September 30, 2020, is as follows (dollar amounts in thousands):
41

Payments Due by Period
TotalLess
than
1 year
1-3 years3-5 yearsAfter 5 years
Subscription Facility$181,350 $— $181,350 $— $— 
Total Contractual Obligations$181,350 $ $181,350 $ $ 

RECENT DEVELOPMENTS

During the period from October 1, 2020 through November 6, 2020, the Company has closed or the Investment Adviser's Investment Committee has committed/approved approximately $274.5 million of new/add-on investments. This includes transactions for which a formal mandate, letter of intent or a signed commitment have been issued, and therefore the Company believes are likely to close. Of these new commitments, approximately 72.5% were first lien senior secured loans, 27.0% were second lien senior secured loans, and 0.5% was common equity. 100% of the senior secured loans were floating rate loans. We expect to continue to carefully invest throughout the fourth quarter of 2020. We remain highly focused on conducting extensive due diligence and leveraging the Morgan Stanley platform. We continue to seek to invest in companies that are led by strong management teams, generate substantial free cash flow, have leading market positions, benefit from sustainable business models, and are well positioned to perform well despite the impact of Coronavirus. We believe the current market environment offers opportunities to seek compelling risk adjusted returns. Our investment pace will depend on several factors including the market environment, deal flow, and the impact of Coronavirus.

While recovery across asset classes continues, subsequent to September 30, 2020, significant volatility and uncertainty remain, including uncertainty relating to another wave of Coronavirus in the United States, domestic unrest, tension with China and the upcoming U.S. elections. These factors may adversely affect the business operations of some, if not all, of our portfolio companies and, and will likely continue to adversely affect, our operations and the operations of our Investment Adviser. While we are closely monitoring this situation, we cannot predict the impact of Coronavirus on our future financial condition, results of operations or cash flows with any level of certainty. For more information, see “Coronavirus Developments” above.

On October 14, 2020, DLF Financing SPV LLC, our wholly-owned subsidiary, a Delaware limited liability company (“DLF
LLC”), entered into a Revolving Credit and Security Agreement (the "Credit and Security Agreement") with DLF LLC, as the borrower, BNP Paribas ("BNP"), as the administrative agent and lender, the Company, as the equityholder and as the servicer, and U.S. Bank National Association, as collateral agent, pursuant to which BNP has agreed to extend credit to DLF LLC in an aggregate principal amount up to $300 million at any one time outstanding (the "BNP Funding Facility").

The BNP Funding Facility is a revolving funding facility with a reinvestment period ending October 13, 2023 and a final
maturity date of October 13, 2025. Subject to certain conditions, the reinvestment period and final maturity are both subject to a one-year extension. Advances under the BNP Funding Facility are available in U.S. dollars, pound sterling, Euro or Canadian dollars, and
subject to certain exceptions, the interest charged on the BNP Funding Facility is based on LIBOR (Dollar), LIBOR (GBP),
EURIBOR or CDOR, as applicable (or, if LIBOR (Dollar) is not available, a benchmark replacement or a “base rate” (which is the
greater of a prime rate and the federal funds rate plus 0.50%), as applicable), plus a margin that generally ranges between 2.25% and
3.25% (depending on the types of assets such advances relate to), with a weighted average margin floor for all classes of advances of
(i) 2.80% during the reinvestment period and (ii) 3.30% following the reinvestment period, with specific margins for non-U.S. dollar
advances as set forth in the Credit and Security Agreement.

The obligations of DLF LLC under the BNP Funding Facility are secured by all of the assets held by DLF LLC, including
certain loans to be sold or transferred by us DLF LLC pursuant to the terms of the Purchase and Sale Agreement (the “Purchase and
Sale Agreement” and, together with the Credit and Security Agreement, the “Agreements”) between the Company and DLF LLC
entered into in connection with the BNP Funding Facility, pursuant to which we will sell to DLF LLC certain loans we have
originated or acquired, or will originate or acquire (the “Loans”) from time to time. Under the Agreements, we and DLF LLC, as
applicable, have made representations and warranties regarding the Loans, as well as our businesses, and are required to comply with
various covenants, servicing procedures, limitations on disposition of Loans, reporting requirements and other customary
requirements for similar revolving funding facilities. The Credit and Security Agreement includes usual and customary events of
42

default for revolving funding facilities of this nature, including allowing BNP, upon a default, to accelerate and foreclose on the
Loans and to pursue the rights under the Loans directly with the obligors thereof. In connection with the entry into the BNP Funding
Facility, DLF LLC also entered into various supporting documentation, including an account control agreement.

Borrowings under the BNP Funding Facility are subject to various covenants under the Agreements as well as the leverage
restrictions contained in the 1940 Act.

CRITICAL ACCOUNTING POLICIES
The preparation of our financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Changes in the economic environment, financial markets, and any other parameters used in determining such estimates could cause actual results to differ. Our critical accounting policies, including those relating to the valuation of our investment portfolio, should be read in connection with our financial statements in Part I, Item 1 of this Form 10-Q, and “Risk Factors” in Part I, Item 1A of the Form 10-K.
RELATED PARTY TRANSACTIONS
We have entered into a number of business relationships with affiliated or related parties, including the following

the Investment Advisory Agreement;
the Administration Agreement;
the Placement Fee Agreement; and
Expense Support and Waiver Agreement.


See “Item 1. Consolidated Financial Statements—Notes to Consolidated Financial Statements—Note 3. Related Party Transactions.

43

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are subject to financial market risks, including valuation risk, market risk and interest rate risk.

Valuation Risk
We have invested, and plan to continue to invest, primarily in illiquid debt and equity securities of portfolio companies. During periods of market dislocation, we will seek to invest prudently in the secondary loan market to provide our investors provide better risk adjusted returns while adhering to our core investment tenants. See “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Coronavirus Developments.” Most of our investments will not have a readily available market price. To ensure accurate valuation, our investments are valued at fair value in good faith by our board of directors, or our Board, based on, among other things, the input of the Investment Adviser, our Audit Committee and independent third-party valuation firm engaged at the direction of the Board, and in accordance with our valuation policy. There is no single standard for determining fair value. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each investment while employing a consistently applied valuation process for the investments we hold. If we were required to liquidate a portfolio investment in a forced or liquidation sale, we may realize amounts that are different from the amounts presented and such differences could be material.

Market Risk

The market value of a security may move up or down, sometimes rapidly and unpredictably. These fluctuations may cause a security to be worth less than the price originally paid for it, or less than it was worth at an earlier time. Market risk may affect a single issuer, industry, sector of the economy or the market as a whole. Global economies and financial markets are increasingly interconnected, which increases the probabilities that conditions in one country or region might adversely impact issuers in a different country or region. Conditions affecting the general economy, including political, social, or economic instability at the local, regional, or global level may also affect the market value of a security. Health crises, such as pandemic and epidemic diseases, as well as other incidents that interrupt the expected course of events, such as natural disasters, war or civil disturbance, acts of terrorism, power outages and other unforeseeable and external events, and the public response to or fear of such diseases or events, have and may in the future have an adverse effect on a company’s investments and net asset value and can lead to increased market volatility. See “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Coronavirus Developments.”

Interest Rate Risk
We are subject to financial market risks, most significantly changes in interest rates. Interest rate sensitivity refers to the change in our earnings that may result from changes in the level of interest rates. Because we expect to fund a portion of our investments with borrowings, our net investment income is expected to be affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. As of December 31, 2019, our exposure to change in interest was immaterial.
In addition, the Coronavirus pandemic has resulted in a decrease in LIBOR and a general reduction of certain interest rates by the U.S. Federal Reserve and other central banks. A continued decline in interest rates, including LIBOR, could result in a reduction of our gross investment income. In addition, our net investment income could also decline if such decreases in LIBOR are not offset by, among other things, a corresponding increase in the spread over LIBOR in our portfolio investments, a decrease in our operating expenses, or a decrease in the interest rates of our liabilities that are tied to LIBOR. See “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Coronavirus Developments.”
As of September 30, 2020, 100% of our debt investments were at floating rates. Based on our Consolidated Balance Sheets as of September 30, 2020, the following table shows the annualized impact on net income of hypothetical base rate changes in interest rates (considering interest rate floors and ceilings for floating rate debt instruments assuming no changes in our investments and borrowing structure as of September 30, 2020) (dollar amounts in thousands):


44

  Interest Interest Net
Basis Point Change - Interest RatesIncomeExpenseIncome
Up 300 basis points$ 7,182 $ (5,441)$ 1,741
Up 200 basis points$ 4,067 $ (3,627)$ 440
Up 100 basis points$ 952 $ (1,814)$ (862)
Down 100 basis points$ (57)$ 269 $ 212
Down 200 basis points$ (57)$ 269 $ 212
Down 300 basis points$ (57)$ 269 $ 212

We may hedge against interest rate fluctuations by using standard hedging instruments such as futures, options and forward contracts or our CIBC Subscription Facility subject to the requirements of the 1940 Act and applicable commodities laws. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in benefits of lower interest rates or higher exchange rates with respect to our portfolio of investments with fixed interest rates or investments denominated in foreign currencies. During the periods covered by this Report, we did not engage in interest rate hedging activities.


45

Item 4: Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures
In accordance with Rules 13a-15(b) and 15d-15(b) of the Exchange Act, we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this Report and determined that our disclosure controls and procedures are effective as of the end of the period covered by this Report.
(b) Changes in Internal Controls Over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

46

Part II - Other Information

Item 1: Legal Proceedings.

    Each of us, the Investment Adviser and the Administrator may become party to certain lawsuits in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Each of us, the Investment Adviser and the Administrator is not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against any of us, the Investment Adviser or the Administrator.


Item 1A: Risk Factors.

In addition to the other information set forth in this Report, you should carefully consider the risk factors discussed below, as well as the risk factors previously disclosed under Item 1A of the Form 10-K, which could materially affect our business, financial condition and/or operating results. The risks described below as well as in the Form 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect our business, financial condition and/or operating results.

We are operating in a period of capital markets disruption and economic uncertainty. The conditions have materially and
adversely affected debt and equity capital markets in the United States, and any future disruptions or instability in capital markets
may have a negative impact on our business and operations.

From time to time, capital markets may experience periods of disruption and instability for a variety of reasons. The outbreak
of Coronavirus beginning in late 2019 and subsequently spreading across the world, including to the United States, has had and could
continue to lead to extreme volatility and disruptions in local, regional, national and global markets and economies affected thereby.
The Coronavirus pandemic has affected and will continue to affect the portfolio companies in which we invest. The Coronavirus
outbreak has resulted in, and until fully resolved is likely to continue to result in, the following among other things: (i) imposition by
various local, state, and federal governmental authorities of various forms of travel restrictions, business closures and other quarantine
measures, resulting in significant disruption to the businesses of many middle market companies including supply chains, demand and
practical aspects of their operations, as well as in lay-offs or furloughs of employees and deferral of capital expenditures, and, while
these effects are hoped to be temporary, some effects could be persistent or even permanent; (ii) potential adverse impacts on the
ability of borrowers to meet loan covenants, post margin or repay loans on a timely basis and on the value of their collateral; (iii)
increased draws by borrowers on revolving lines of credit, which lenders, including the Company, may not have the ability under the
applicable credit agreement to refuse to fund without the Company being in default and suffering financial penalties; (iv) increased
requests by borrowers for amendments and waivers of their credit agreements to avoid default, increased defaults by such borrowers
and/or increased difficulty in obtaining refinancing at the maturity dates of their loans; (v) potential increased disputes with
counterparties who assert that failure to perform (or delay in performing) might be excused under so called “material adverse change,”
force majeure and similar provisions in such contracts; (vi) volatility and disruption of markets including greater volatility in pricing
and spreads, difficulty in valuing loans during periods of increased volatility, and liquidity issues; (vii) reduction in certain interest
rates by the U.S. Federal Reserve and other central banks and decreased LIBOR; (viii) unfavorable economic conditions that would be
expected to increase borrowers’ funding costs, limit borrowers’ access to the capital markets or result in a decision by lenders not to
extend credit to borrowers; and (ix) rapidly evolving proposals and/or actions by local, state and federal governments to address
problems being experienced by the markets and by businesses and the economy in general which will not necessarily adequately
address the problems facing the loan market and middle market companies. In this environment, there is a heightened likelihood of
government intervention or regulation and/or changes in law, including by way of example laws and regulations requiring lenders such
as the Company to waive payments from borrowers, defer maturities on loans and/or cancel or delay foreclosures on a borrower’s
assets, any of which could have a material adverse effect on the Company and its investments.

Such capital markets disruptions and instability have also occurred in the past and may occur in the future. For example,
from 2008 to 2009, the global capital markets were unstable as evidenced by the lack of liquidity in the debt capital markets,
significant write-offs in the financial services sector, the re-pricing of credit risk in the broadly syndicated credit market and the failure
of major financial institutions. Despite actions of the U.S. federal government and various foreign governments, these events contributed to worsening general economic conditions that materially and adversely impacted the broader financial and credit markets

47

and reduced the availability of debt and equity capital for the market as a whole and financial services firms in particular. There have
been more recent periods of volatility and there can be no assurance that adverse market conditions will not repeat themselves in the
future. Furthermore, uncertainty between the United States and other countries with respect to trade policies, treaties and tariffs,
among other factors, have caused disruptions in the global markets, and we cannot assure you that these market conditions will not
continue or worsen in the future. Terrorist acts, acts of war, natural disasters, or disease outbreaks, pandemics or other public health
crises may cause periods of market instability and volatility and may disrupt the operations of us and our portfolio companies for
extended periods of time. If similar adverse and volatile market conditions repeat in the future, we and other companies in the financial services sector may have to access, if available, alternative markets for debt and equity capital in order to grow. Equity capital may be particularly difficult to raise during periods of adverse or volatile market conditions because, subject to some limited exceptions, as a BDC, we are generally not able to issue additional shares of Common Stock at a price less than the net asset value per share without first obtaining approval for such issuance from our stockholders and our Board, including all of our directors who are not "interested persons" of us, as defined in the 1940 Act.

Moreover, the re-appearance of market conditions similar to those experienced from 2008 through 2009 for any substantial
length of time or worsened market conditions, including as a result of United States government shutdowns or the perceived
creditworthiness of the United States, could make it difficult for us to borrow money or to extend the maturity of or refinance any
indebtedness we may have under similar terms and any failure to do so could have a material adverse effect on our business. The debt
capital that will be available to us in the future, if any, may be at a higher cost and on less favorable terms and conditions than would
currently be available. If we are unable to raise or refinance debt, stockholders may not benefit from the potential for increased returns
on equity resulting from leverage and we may be limited in our ability to make new commitments or to fund existing commitments to
our portfolio companies.

Given the periods of extreme volatility and dislocation in the capital markets from time to time, many BDCs have faced, and
may in the future face, a challenging environment in which to raise or access capital. In addition, significant changes in the capital
markets, including the extreme volatility and disruption over the past several years, has had, and may in the future have, a negative
effect on asset valuations and on the potential for liquidity events. While most of our investments will not be publicly traded,
applicable accounting standards require us to assume as part of our valuation process that our investments are sold in a principal
market to market participants (even if we plan on holding an investment through to maturity). As a result, volatility in the capital
markets can adversely affect the valuations of our investments. Further, the illiquidity of our investments may make it difficult for us to sell such investments to access capital if required. As a result, we could realize significantly less than the value at which we have recorded our investments if we were required to sell them for liquidity purposes. In addition, a prolonged period of market illiquidity may cause us to reduce the volume of loans and debt securities we originate and/or fund and adversely affect the value of our portfolio
investments, which could have a material and adverse effect on our business, financial condition, results of operations and cash flows.
An inability to raise or access capital could have a material adverse impact on our business, financial condition or results of
operations.

In addition, U.S. and non-U.S. governments have enacted or may enact various regulations that may impact Morgan Stanley
or us, our investments, our opportunities and our investors. New regulations, changing regulatory schemes and the burdens of
regulatory compliance may have a material negative impact on our performance and the performance of our portfolio companies. For
example, recent proposals relating to the activities of bank holding companies may adversely affect Morgan Stanley's (including the
Investment Adviser's) ability to sponsor and/or invest in private funds, including us.

Terrorist attacks, acts of war, natural disasters, outbreaks or pandemics, such as the Coronavirus pandemic, may impact our portfolio companies and our Investment Adviser and harm our business, operating results and financial condition.

Terrorist acts, acts of war, natural disasters, disease outbreaks, pandemics or other similar events may disrupt our operations, as well as the operations of our portfolio companies and our Investment Adviser. Such acts have created, and continue to create,
economic and political uncertainties and have contributed to recent global economic instability. For example, many countries have
experienced outbreaks of infectious illnesses in recent decades, including swine flu, avian influenza, SARS and Coronavirus.

The ongoing spread of the Coronavirus has had, and will continue to have, a material adverse impact on local economies in
the affected jurisdictions and also on the global economy, as cross border commercial activity and market sentiment are increasingly
impacted by the outbreak and government and other measures seeking to contain its spread. In addition to these developments having adverse consequences for certain portfolio companies and other issuers in or through which we invest and the value of our investments

48

therein, the operations of the Investment Adviser (including those relating to us) have been, and could continue to be, adversely
impacted, including through quarantine measures, business closures and travel restrictions imposed on Morgan Stanley personnel or
service providers based or temporarily located in affected countries, or any related health issues of such personnel or service
providers. Any of the foregoing events could materially and adversely affect our ability to source, manage and divest its investments
and its ability to fulfill its investment objectives. Similar consequences could arise with respect to other comparable infectious
diseases. As the potential impact of the Coronavirus is difficult to predict, the extent to which the Coronavirus and/or other disease
outbreaks or health pandemics may negatively affect our and our portfolio companies' operating results, or the duration of any
potential business or supply-chain disruption, is uncertain. Any potential impact to our results will depend to a large extent on future
developments and new information that may emerge regarding the duration and severity of the Coronavirus and the actions taken by
authorities and other entities to contain the Coronavirus or treat its impact, all of which are beyond our control. These potential
impacts, while uncertain, could adversely affect our and our portfolio companies' operating results. In addition, future terrorist
activities, military or security operations, natural disasters, disease outbreaks, pandemics or other similar events could weaken the
domestic/global economies and create additional uncertainties, which may negatively impact our portfolio companies and, in turn,
could have a material adverse impact on our business, operating results and financial condition.

If the current period of capital markets disruption and economic uncertainty continues for an extended period of time,
there is a risk that you may not receive distributions or that our distributions may not grow over time and a portion of our
distributions may be a return of capital.

We intend to make periodic distributions to our stockholders out of assets legally available for distribution. We cannot assure
you that we will achieve investment results that will allow us to make a specified level of cash distributions or year-to-year increases in cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors
described in this report or incorporated herein by reference, including the Coronavirus pandemic described above. For example, if the
temporary closure of many corporate offices, retail stores, and manufacturing facilities and factories in the jurisdictions, including the
United States, affected by the Coronavirus pandemic were to continue for an extended period of time it could result in reduced cash
flows to us from our portfolio companies, which could reduce cash available for distribution to our stockholders. Due to the asset
coverage test applicable to us under the 1940 Act as a BDC, we may be limited in our ability to make distributions. To the extent we
make distributions to stockholders that include a return of capital, such portion of the distribution essentially constitutes a return of the
stockholder's investment. Although such return of capital may not be taxable, such distributions may increase an investor's tax liability
for capital gains upon the future sale of our Common Stock. A return of capital distribution may cause a stockholder to recognize a
capital gain from the sale of our Common Stock even if the stockholder sells its shares for less than the original purchase price.

Our ability to enter into transactions with our affiliates will be restricted.

We are prohibited under the 1940 Act from participating in certain transactions with certain of our affiliates without the prior
approval of a majority of our independent directors and, in some cases, the SEC. Any person that owns, directly or indirectly, 5% or
more of our outstanding voting securities is our affiliate for purposes of the 1940 Act, and we are generally prohibited from buying or
selling any securities from or to such affiliate on a principal basis, absent the prior approval of our Board of Directors and, in some
cases, the SEC. The 1940 Act also prohibits certain “joint” transactions with certain of our affiliates, which in certain circumstances
could include investments in the same portfolio company (whether at the same or different times to the extent the transaction involves
a joint investment), without prior approval of our Board of Directors and, in some cases, the SEC. If a person acquires more than 25%
of our voting securities, we are prohibited from buying or selling any security from or to such person or certain of that person’s
affiliates, or entering into prohibited joint transactions with such persons, absent the prior approval of the SEC. Similar restrictions
limit our ability to transact business with our officers or directors or their affiliates.

The SEC has interpreted the BDC regulations governing transactions with affiliates to prohibit certain joint transactions involving entities that share a common investment adviser. As a result of these restrictions, we may be prohibited from buying or selling any security from or to any portfolio company that is controlled by a fund managed by the Adviser or their respective affiliates without the prior approval of the SEC, which may limit the scope of investment opportunities that would otherwise be available to us.
We may, however, invest alongside our Adviser’s and/or its affiliates’ other clients, in certain circumstances where doing so is
consistent with applicable law and SEC staff interpretations, guidance and exemptive relief orders. However, although the Adviser
endeavors to fairly allocate investment opportunities in the long-run, we can offer no assurance that investment opportunities will be
allocated to us fairly or equitably in the short-term or over time. On September 18, 2020, the SEC granted us exemptive relief that


49

allows us to enter into certain negotiated co-investment transactions alongside certain Affiliated Investment Accounts in a manner consistent with our investment objective, positions, policies, strategies, and restrictions as well as regulatory requirements and other pertinent factors, subject to compliance with the Order. Pursuant to the Order, we are permitted to co-invest with our affiliates if a “required majority” (as defined in Section 57(o) of the 1940 Act) of our eligible directors make certain conclusions in connection with a co-investment transaction, including that (1) the terms of the transactions, including the consideration to be paid, are reasonable and fair to us and our stockholders and do not involve overreaching in respect of us or our stockholders on the part of any person concerned, and (2) the transaction is consistent with the interests of our stockholders and is consistent with our investment objective and strategies.

In situations when co-investment with affiliates’ other clients is not permitted under the 1940 Act and related rules, existing or future staff guidance, or the terms and conditions of the exemptive relief granted to us by the SEC (as discussed above), our Adviser will need to decide which client or clients will proceed with the investment. Generally, we will not have an entitlement to make a coinvestment in these circumstances and, to the extent that another client elects to proceed with the investment, we will not be permitted to participate. Moreover, except in certain circumstances, we will not invest in any issuer in which an affiliate’s other client holds a controlling interest.

We intend to finance our investments with borrowed money, which will magnify the potential for gain or loss on amounts
invested and may increase the risk of investing in us.

The use of leverage magnifies the potential for gain or loss on amounts invested. The use of leverage is generally considered a speculative investment technique and increases the risks associated with investing in our securities. The amount of leverage that we employ will be subject to the restrictions of the 1940 Act and the supervision of our Board of Directors. At the time of any proposed borrowing, the amount of leverage we employ will also depend on our Adviser's assessment of market and other factors. We cannot assure you that we will be able to obtain credit at all or on terms acceptable to us. For example, due to the interplay of the 1940 Act restrictions on principal and joint transactions and the U.S. risk retention rules adopted pursuant to Section 941 of Dodd-Frank, as a BDC we are limited in our ability to enter into any securitization transactions. We cannot assure you that the SEC or any other regulatory authority will modify such regulations or provide administrative guidance that would give us greater flexibility to enter into securitizations. We may issue senior debt securities to banks, insurance companies and other lenders. Lenders of these senior securities hat are superior to the claims of our common stockholders, and we would expect such lenders to seek recovery against our assets in the event of a default. We may pledge up to 100% of our assets, may grant a security interest in all of our assets and may pledge the right to make capital calls of stockholders under the terms of any debt instruments we may enter into with lenders. The terms of our existing indebtedness require us to comply with certain financial and operational covenants. Failure to comply with such covenants could result in a default under the applicable credit facility or debt instrument if we are unable to obtain a waiver from the applicable lender or holder, and such lender or holder could accelerate repayment under such indebtedness and negatively affect our business, financial condition, results of operations and cash flows. In addition, under the terms of any credit facility or other debt instrument we enter into, we are likely to be required by its terms to use the net proceeds of any investments that we sell to repay a portion of the amount borrowed under such facility or instrument before applying such net proceeds to any other uses. If the value of our assets decreases, leveraging would cause our net asset value to decline more sharply than it otherwise would have had we not leveraged, thereby magnifying losses or eliminating our equity stake in a leveraged investment. Similarly, any decrease in our net investment income will cause our net income to decline more sharply than it would have had we not borrowed. Such a decline would also negatively affect our ability to make distributions on our Common Stock or any outstanding preferred stock. Our ability to service our debt depends largely on our financial performance and is subject to prevailing economic conditions and competitive pressures. Our common stockholders bear the burden of any increase in our expenses as a result of our use of leverage, including interest expenses and any increase in the base management fee payable to the Adviser.

As a BDC, we generally are required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include our borrowings and any preferred stock that we may issue in the future, which is currently 150%. If this ratio were to decline below 150% (or such other percentage as may be prescribed by law from time to time), we could not incur additional debt and could be required to sell a portion of our investments to repay some debt when it was disadvantageous to do so. This could have a material adverse effect on our operations, and we may not be able to make distributions in amounts sufficient to maintain our status as a RIC, or at all.




50

We are subject to risks associated with the CIBC Subscription Facility and the BNP Funding Facility and any other Credit Facility.

On December 31, 2019, we entered into the CIBC Subscription Facility with CIBC Bank USA as administrative agent and
arranger. On October 14, 2020, DLF LLC, our wholly owned subsidiary, entered into the BNP Funding Facility. As a result of the
CIBC Subscription Facility and the BNP Funding Facility and any other credit facility that we or a subsidiary of ours may enter into in
the future (each, a “Credit Facility”), we are subject to a variety of risks, including those set forth below.

Any inability to renew, extend or replace the CIBC Subscription Facility, the BNP Funding Facility, or any other Credit Facility could adversely impact our liquidity and ability to find new investments or maintain distributions to our stockholders.

There can be no assurance that we would be able to renew, extend or replace the CIBC Credit Facility, the BNP Funding Facility, or any other Credit Facility upon its maturity on terms that are favorable to us, if at all. Our ability to renew, extend or replace these credit facilities would be constrained by then-current economic conditions affecting the credit markets. In the event that we were not able to renew, extend or replace the CIBC Subscription Facility, the BNP Funding Facility or any other Credit Facility at the time of its maturity, this could have a material adverse effect on our liquidity and ability to fund new investments, our ability to make
distributions to our stockholders and our ability to qualify as a RIC.

In addition to regulatory limitations on our ability to raise capital, each of the CIBC Subscription Facility and the BNP Funding Facility contains various covenants, which, if not complied with, could accelerate our repayment obligations under such credit facility, thereby materially and adversely affecting our liquidity, financial condition, results of operations and ability to pay distributions.

The CIBC Subscription Facility is secured by the unfunded commitments of certain investors of the Company and the BNP
Funding Facility is secured by all of the assets held by DLF LLC, including certain loans we sell or transfer to DLF LLC. In each of the
CIBC Subscription Facility and the BNP Funding Facility, we have made customary representations and warranties and are required to
comply with various covenants, reporting requirements and other customary requirements for similar credit facilities. Our continued
compliance with the covenants contained in the respective documents governing the CIBC Subscription Facility and the BNP Funding
Facility depends on many factors, some of which are beyond our control. We can offer no assurances that we will continue to comply
with these covenants.

In the event of a default under the CIBC Subscription Facility documents, CIBC Bank USA, in its capacity as administrative agent under the CIBC Subscription Agreement documents, would have the right to call the capital commitments of our investors collateralizing the CIBC Subscription Agreement in order to repay amounts outstanding under the CIBC Subscription Agreement, which would reduce the amount of capital commitments available to us for investment purposes and thereby have a material adverse effect on our business, liquidity, financial condition, results of operations and ability to pay distributions to our stockholders.
In the event of a default under the BNP Funding Facility documents, BNP, in its capacity as administrative agent under BNP Funding Facility documents, would have the right to require us to sell assets held by DLF LLC and use the proceeds to repay our obligations under the BNP Funding Facility, which would reduce the number of investments we hold and thereby have a material adverse effect on our business, liquidity, financial condition, results of operations and ability to pay distributions to our stockholders.

Our interests in DLF LLC are subordinated, and we may not receive cash on our equity interests from such subsidiary.

We consolidate the financial statements of DLF LLC in our financial statements and treat the indebtedness of DLF LLC as our leverage. Our interests in DLF LLC are subordinated in priority of payment to every other obligation of DLF LLC and are subject to certain payment restrictions set forth in the BNP Funding Facility. We receive cash distributions on our equity interests in DLF LLC
only if DLF LLC had made all required cash interest payments to the lenders and no default exists under the BNP Funding Facility.
We cannot assure you that distributions on the assets held by DLF LLC will be sufficient to make any distributions to us or that such
distributions will meet our expectations.

We receive cash from DLF LLC only to the extent that we receive distributions on our equity interests in DLF LLC. DLF LLC is able to make distributions on its equity interests only to the extent permitted by the payment priority provisions of the BNP Funding Facility. The BNP Funding Facility generally provides that payments on our interests in DLF LLC may not be made on any

51

payment date unless all amounts owing to the lenders and other secured parties are paid in full. In addition, if DLF LLC does not meet the borrowing base test set forth in the BNP Funding Facility documents, a default would occur. In the event of a default under the BNP Funding Facility documents, cash would be diverted from us to pay the lender and other secured parties until they would be paid in full. In the event that we fail to receive cash from DLF LLC, we could be unable to make distributions to our stockholders in amounts sufficient to maintain our status as a RIC, or at all. We also could be forced to sell investments in portfolio companies at less than their fair value in order to continue making such distributions.

Our equity interests in DLF LLC rank behind all of the secured and unsecured creditors, known or unknown, of DLF, including the lenders in the BNP Funding Facility. Consequently, to the extent that the value of DLF LLC’s portfolio of loan investments is reduced as a result of conditions in the credit markets, defaulted loans, capital gains and losses on the underlying assets, prepayment or changes in interest rates, the return on our investment in DLF LLC could be reduced. Accordingly, our investment in DLF LLC may be subject to up to a complete loss.

Our ability to sell investments held by DLF LLC is limited.

The BNP Funding Facility places significant restrictions on our ability, as servicer, to sell investments held by DLF LLC. As a result, there may be times or circumstances during which we would be unable to sell investments or take other actions that might be in our best interests.

52

Item 2: Unregistered Sales of Equity Securities and Use of Proceeds.

Sales of Unregistered Securities
Refer to "Item 1. Financial Statements—Notes to Consolidated Financial Statements—Note 8. Net Assets" in this Report and our Current Reports on Form 8-K filed on August 13, 2020 and October 1, 2020, for issuances of our Common Stock during the quarter ended September 30, 2020. Such issuances were part of our Private Offering pursuant to Section 4(a)(2) of the Securities Act and Regulation D thereunder.
Issuer Purchases of Equity Securities
None.

Item 3: Defaults Upon Senior Securities.

    None.


Item 4: Mine Safety Disclosures.

    Not applicable


Item 5: Other Information.

    None.



53



Item 6: Exhibits.

EXHIBIT INDEX

_________________
* Filed herewith



54




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.


Morgan Stanley Direct Lending Fund
Dated: November 6, 2020
By/s/ Jeffrey S. Levin
Jeffrey S. Levin
President and Chief Executive Officer
(Principal Executive Officer)
Dated: November 6, 2020
By/s/ Venugopal Rathi
Venugopal Rathi
Chief Financial Officer
(Principal Financial Officer)


55